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ABSTRACT 
 Male rat mating is a suite of individual behaviors mediated by the actions of two 
metabolites of testosterone (T), dihydrotestosterone (DHT) and estradiol (E2), on the 
brain.  Individually, neither metabolite fully maintains or restores mating in castrated 
males, but both combined are as effective as T.  Two hormone-responsive areas of the 
brain, the medial preoptic area (MPO) and the medial amygdala (MEA), are crucial for 
mating.  These studies ask:  by what mechanism(s) does E2 act in the MPO and MEA?  
We blocked the conversion of T to E2 in the MEA of intact male rats and sexual behavior 
was not maintained.  We then infused antisense oligodeoxynucleotides (ODNs) to 
estrogen receptor-alpha (ER-α) mRNA bilaterally to the MPO or the MEA of intact male 
rats to block ER-α expression.  ODN infusion of the MPO attenuated mating but infusion 
of the MEA had no effect.  These results suggest that ER-α is the behaviorally relevant 
estrogen receptor (ER) in the MPO but not in the MEA.  ER was originally described in 
the cytoplasm and nucleus of cells.  Recently plasma membrane associated ERs (mER) 
have been reported.  We conjugated E2 to Bovine Serum Albumin (BSA-E2), a large 
protein that will not penetrate the plasma membrane, thus restricting the action of E2 to 
mER, and chronically delivered it to the MPO and MEA.  BSA-E2 maintained mating if 
put in the MPO, but not in the MEA, suggesting a surface action of E2 is sufficient in the 
MPO.  The MPO and MEA are reciprocally connected and probably constitute elements 
of a larger, steroid-responsive neural network that mediates male mating behavior.  To 
begin to describe this purported circuit, we injected Pseudorabies virus (PRV) into the 
prostate gland and dually labeled PRV-immunoreactive cells for ER or androgen 
receptors.  We found dual labeling in a forebrain diencephalic circuit that includes the 
MPO, the medial preoptic nucleus, bed nucleus of stria terminalis, the zona incerta, the 
periaqueductal gray and other areas that presumably mediate both autonomic and motor 
aspects of male mating.  Together, the results of these studies begin to elucidate locations 
and mechanisms of E2 mediation of male sexual behavior.   
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INTRODUCTION 
 In vertebrates, the expression of male copulatory behavior depends on testicular 
testosterone (T) and its metabolites.  Gonadal hormones not only maintain peripheral 
structures, but also act on the central nervous system, orchestrating a suite of individual 
behaviors that range from premating rituals to successful insemination.  For thousand of 
years, farmers and sheiks have utilized the physiological changes induced by castration.  
In our modern world we have developed the ability to manipulate hormones to give 
desired effects (birth control, fertility, libido enhancement and inhibition), yet the exact 
action of a single hormone or the specific mechanism of any hormone’s effect on the 
brain and sexual behavior is not understood.  Sexual behavior is a complex mixture of 
motivation, learned behavior, natural instinct, and rapidly changing physiological states.  
Presumably, the “conductor” of this “orchestra” is the central nervous system.  Hormones 
cause cellular changes in neurons of the brain and spinal cord coordinating both the 
physiological and behavioral aspects of mating, but whether these changes are 
activational, permissive, or inhibitory is unknown.  The studies presented here do not 
fully answer these questions and in fact, raise more questions for future research.  
Nevertheless, these findings will hopefully add pieces to the picture that will one day 
explain the activation affects of hormones on the brain and their transduction into male 
sexual behavior. 
 Studies of the central regulation of any behavior, by necessity, require 
identification of the anatomical locations that govern the behavior as well as the 
neuropharmacological functioning of these sites.  These studies are concerned with the 
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actions of gonadal steroids on the MPO and MEA, two sites that are important for male 
sexual behavior.  T is enzymatically metabolized to dihydrotestosterone (DHT) by 5-α-
reductase [90] and to estradiol (E2) by aromatase [108].  Numerous hormone 
manipulation studies have suggested that individually, neither DHT nor E2 is as effective 
in maintaining or restoring male copulatory behavior as is a combination of the two [158] 
or as is T.  Today, there is a consensus that hormonal control of male mating behavior 
depends on both metabolites of T and probably T itself.  
 Lesion studies have suggested that several brain areas such as the medial preoptic 
area (MPO), the bed nucleus of the stria terminalis (BST) the central tegmental field 
(CTF) and the amygdala, among others contribute to the expression of copulatory 
behavior [63, 97].  The MPO, believed to be center for integration, is crucial for male 
mating behavior.  Lesions, either electrical [28, 78, 80] or chemical [56, 80], of the MPO 
attenuate mating, whereas stimulation of the MPO, either electrical [87, 153] or chemical 
[43, 44], promotes it.  Knife cut experiments severing various connections afferent and 
efferent to the MPO have suggested that the efferent connections from the MPO to the 
median forebrain bundle are crucial to the display of mating behavior [14].  In every 
vertebrate studied to date, the absence of a functional MPO results in an inability to mate.  
Lesions of the BST and/or the stria terminalis (st; a fiber tract that connects the amygdala 
with the MPO) interrupt male mating but to a lesser extent than do lesions of the MPO.  
Specifically, BST and st lesions generally affect the cadence of mating, resulting in 
increased frequencies of behaviors preceding ejaculation and longer latencies until 
ejaculation occurs [45, 48, 150, 177].  Electrical lesions of subnuclei of the amygdala, 
 3
namely the medial amygdala (MEA) cause severe impairment of mating behavior [71] 
while other reports suggest a temporal or timing disruption similar to lesions of the BST 
[80].  Nevertheless, the importance of the MEA in male mating behavior cannot be 
discounted.  In all probability the MPO and the MEA function as a unit by controlling 
and integrating different aspects of the behavior [40, 74, 171].   
 Fos, the protein product of the early immediate gene c-fos, is accepted as a 
correlational marker for neuronal metabolic activity [131].  Supporting previous studies, 
mating-induced Fos-immunoreactivity (-ir) is increased in brain areas known to mediate 
mating, namely the MPO, BST, MEA and CTF [8, 36, 70].  Moreover, Fos-ir associated 
with mating is colocalized with either AR-ir or ER-ir alone, or both AR-ir and ER-ir in 
neurons of these same brain areas [51].  Anatomical tract tracing studies show reciprocal 
connections between these areas [18, 38, 39, 52, 136], raising the possibility that, in 
males, there is an interconnected, steroid-responsive neural network that mediates male 
mating behavior, similar to the network that governs the lordotic reflex in female rats 
[41].  In all probability, such a network does exist, but little is known about the specifics 
of the steroid-responsiveness.  Systemic T given to castrated male rats is capable of 
maintaining [163] or reinstating [43] male sexual behavior, however, some studies 
suggest that it is the conversion of T to E2 that stimulates mating rather than T alone [83, 
84,141].  Furthermore, sexual behavior is reinstated in castrated males that receive T or 
E2 implants to the MPO [43, 44], and exogenous T plus anti-estrogens are insufficient to 
reinstate behavior in castrated males [83], suggesting that estrogen might play a larger 
role in the expression of male sexual behavior than previously imagined.   
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 Previous studies from our laboratory using subcutaneous (s.c.) administration of 
Fadrozole (CGS-16949A, CIBA-Geigy Corporation, Summit, NJ), an aromatase enzyme 
inhibitor, significantly decreases the conversion of [3H]T to [3H]E2 in male rat 
hypothalamic and amygdaloid nuclear fractions [12].  Moreover, administering Fadrozole 
s.c. (but not vehicle) to castrated, T-maintained male rats significantly decreases mating 
behavior, and subsequent administration of E2 partially restores some copulatory 
behaviors [12].  Chronic intracranial infusion of Fadrozole (but not saline) bilaterally to 
the MPO of intact male rats also significantly decreases mating [32].  Conversely, mating 
behavior is maintained in intact males given chronic Fadrozole s.c. (to block T 
aromatization throughout the brain) together with bilateral MPO implants of E2 (but not 
vehicle) [33].  Clearly, the action of E2 in the MPO is crucial for the display of male 
copulatory behavior, but what about the MEA?  To examine the role of E2 in the MEA, 
we used the same experimental approach as described above.  In Chapter 2, Fadrozole 
was chronically and bilaterally infused to the MEA of intact male rats, which were 
subsequently tested with receptive females and scored for the expression of sexual 
behavior.  The results of the converse experiment are reported in the Appendix:  chronic 
Fadrozole s.c. together with bilateral E2 implants (but not vehicle implants) aimed at the 
MEA maintain mounting and intromissive behaviors in intact males.  Ejaculations 
however, are not maintained.   
Obviously, E2 also acts in the MEA to mediate male sexual behavior, but the 
exact mechanism(s) of E2 action is misunderstood.  Historically, ER (found in both the 
MPO and the MEA) was known to act as a transcription factor, regulating gene 
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expression [64, 68, 93, 164].  Recently, there have been reports of ER associated with the 
plasma membrane (mER) [88, 101, 148] or intracellular membranes [128, 176] that act 
rapidly initiating a cascade of cell-signaling effects that might or might not culminate in 
gene transcription [160].  In 1996, a novel ER was described [76] as ER-β, causing the 
previously discovered ER to be called ER-α.  Behavioral studies suggest that mice 
genetically altered to be deficient in the expression of ER- α do not mate [112, 129] 
whereas mice with ER- β deficiencies mate at levels that are not significantly different 
from wild type [111].  We have previously shown that E2 functions in the MPO and MEA 
to promote mating behavior.  We hypothesized that if, as suggested, ER-α is behaviorally 
relevant for mating, then selective removal of ER-α from the MPO and MEA of male rats 
should reduce mating.  To test this hypothesis we used bilateral chronic infusion of 
antisense oligodeoxynucleotides complementary to the start translation site of ER-α 
mRNA to knockdown the expression of ER-α in the MPO and MEA of intact male rats 
and tested them with sexually receptive females. 
Because of the numerous recent reports of mER cell-signaling we wondered if 
these signaling cascades were important in the expression of specific behaviors.  Initially, 
such rapid signals were considered to be “non-genomic” in nature; however, research is 
beginning to suggest that these rapid signals and genomic effects are not mutually 
exclusive [160].  Hormones can be conjugated to Bovine Serum Albumin (BSA - a large 
protein that does not cross the cellular plasma membrane) and used to stimulate only 
those receptors associated with the membrane.  Thus, conjugated steroids are an excellent 
tool for studying the effects of membrane-associated receptors.  Surprisingly, most of the 
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studies using conjugated steroids have been conducted in vitro.  Reports of in vivo studies 
of the behavioral effects of membrane-associated receptors are rare, however it has been 
shown that progesterone conjugated to BSA, when administered to the ventral tegmental 
area, elicits lordosis in estrogen-primed female rats [47].  Therefore, we used E2 
conjugated to BSA (BSA-E2) to explore the behavioral effects of mER via chronic 
bilateral delivery to either the MPO or MEA of castrated, DHT-maintained male rats. 
 Finally, if a steroid-responsive neural network for male sexual behavior exists, 
then, based on lesion, autoradiography, Fos-ir and hormone manipulation studies, brain 
areas previously described, such as the MPO, BST, MEA and CTF, should be 
components of the circuit.  This circuit should show steroid hormone sensitivity and 
connectivity to peripheral structures involved in mating and insemination.  Recently a 
series of studies have described a spinal ejaculation generating center in the lumbar spinal 
cord [35, 149].  Ejaculation, however is a reflex (as is lordosis), and its expression 
presumably can be influenced by supraspinal elements in the brain.  Moreover, because 
not all sexual behavior culminates in ejaculation, we hypothesized that there must be a 
supraspinal circuit for mating behavior that integrates exogenous sensory cues with the 
motor output needed to initiate mating behavior, thus synchronizing and coordinating 
sexual response. 
 To test the hypothesis we injected an attenuated form of the pseudorabies 
virus (PRV), the Bartha’s K strain, a transneuronal, retrograde tract tracer, into a 
peripheral structure that is activated during mating, the prostate gland.  When this viral 
strain is introduced peripherally, it is taken up by autonomic motor neuron terminals 
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[144].  Inside the infected neuron, the virus self-replicates and is transferred across 
synapses in a retrograde fashion to presynaptic axon terminals.  Provided there is no cell 
lysis, the process is repeated and viral infection spreads from neuron-to-neuron in a 
chain-like fashion [19, 20] such that, with anti-PRV ICC, an entire multisynaptic neural 
network that presumably controls the functions of the peripheral structure can be 
visualized.  We elected to infect the prostate gland with PRV because the expulsion of 
prostatic fluid is temporally synchronized with the ejaculatory behavioral pattern, which 
suggests that activity in a common, supraspinal circuit may trigger both the expulsion of 
prostatic fluid and the behavioral patterns associated with mating behavior.  We reasoned 
that PRV would infect the central neural network underlying mating behavior and we 
predicted that this network would be composed of steroid-sensitive neurons.  Brains were 
dually processed for the expression of PRV-ir and either ER-ir or AR-ir and we 
anticipated finding a high proportion of dual-labeled neurons in brain areas known to 
mediate male rat sexual behavior.   
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CHAPTER 1 
 
INHIBITION OF ESTROGEN RECEPTOR SYNTHESIS IN THE MEDIAL 
PREOPTIC AREA, BUT NOT THE MEDIAL AMYGDALA, REDUCES MALE 
RAT COPULATORY BEHAVIOR 
 
Jacquelyn C. Paisley, Gloria G. Huddleston, Laura L. Carruth, Matthew S. Grober, Aras 
Petrulis and Andrew N. Clancy, Journal of Neuroscience, in preparation, 2006. 
 
Portions of this chapter are based on the Masters Thesis of J. C. Paisley. 
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ABSTRACT 
Male rat sexual behavior depends on the actions of gonadal hormones on 
steroid-sensitive neurons in the brain.  Mating-induced Fos-immunoreactivity (ir) 
is colocalized with estrogen receptors (ER) in neurons of the medial preoptic area 
(MPO) and the medial amygdala (MEA), and inhibiting the aromatization of 
testosterone to estradiol (E2) in either of these areas impairs mating, whereas E2 
implants to either area facilitate it.  Because several studies suggest that ERα is the 
behaviorally relevant form of ER, we hypothesized that E2 acts via ERα in the 
MPO and MEA to mediate mating.  To test the hypothesis, we used bilateral 
infusions of an antisense oligodeoxynucleotide (AS-ODN) complementary to ERα 
mRNA, to either the MPO or the MEA of intact male rats, thus blocking the 
synthesis and expression of ERα in those brain areas.  Infusion of AS-ODN 
significantly reduced expression of ERα-ir in both the MPO and MEA relative to 
control infusions.  Furthermore, males receiving AS-ODN to the MPO exhibited 
significant deficits in the numbers of mounts, intromissions and ejaculations 
compared to controls.  However, males receiving AS-ODN to the MEA continued 
to mate normally.  These results suggest: (i) that ERα is the behaviorally relevant 
form of ER in the MPO but not the MEA and (ii) that E2 has differential actions in 
these two brain areas.  
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INTRODUCTION 
 Lesion [28, 56, 78], stimulation [87, 153] and hormone manipulation studies [43, 
44] have all shown that a functional medial preoptic area (MPO) is crucial for male rat 
mating behavior, moreover, mating-induced Fos immunoreactivity (-ir) is colocalized in 
neurons of the MPO that contain androgen receptors (AR), estrogen receptors (ER) or 
both AR and ER [51].  In the brain, testicular testosterone (T) is enzymatically converted 
to dihydrotestosterone (DHT) via 5-alpha reductase [90] and to estradiol (E2) via 
aromatase [108].  Blockade of the conversion of T to E2 via Fadrozole, (a non-steroidal 
aromatase enzyme inhibitor, CGS-16949A, CIBA-Geigy Corporation, Summit, NJ) 
administered either systemically [12] or locally into the MPO [32] attenuates mating 
behavior, an effect that is reversed by systemic E2 [12].  Furthermore, implants of E2 
confined to the MPO maintain mating behavior in male rats given systemic Fadrozole 
[33].  Thus, estrogenic metabolites of T, acting in the MPO, are crucial for the expression 
of male mating.   
 The medial amygdala (MEA) also colocalizes ER and mating-induced Fos-ir [51].  
Reproductively significant olfactory [110], chemosensory [37, 110] and somatosensory 
[8, 52] stimuli are received and processed in the MEA, which is heavily reciprocally 
interconnected with the MPO [18, 136].  Electrolytic lesions of the MEA [57] or knife 
cuts [73, 150] of pathways connecting the MEA and MPO produce severe deficits in 
mating behavior.  Moreover, blocking T aromatization in the MEA reduces sexual 
behavior [60], and E2 implants confined to the MEA maintain mounts and intromissions, 
but not ejaculations [59] in male rats administered Fadrozole systemically.  Although a 
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functional MPO appears to be sufficient for the expression of copulation, it is likely that 
the MEA and MPO operate together (perhaps as a unit) to mediate copulatory behavior 
[72] and that the MEA facilitates mating.   
 It is evident from these studies that responses to E2 occur in the MPO and MEA 
leading to normal male mating behavior.  The mechanism(s) of estrogen action, however, 
have yet to be clarified, although recent research suggests that hormone-bound neuronal 
steroid receptors exert their effects by acting in conjunction with one or more steroid 
receptor cofactor (SRC) proteins.  Inactivation of these SRCs [27, 103] or ER itself [91] 
via intracranial delivery of antisense oligodeoxynucleotides (ODNs) complementary to 
their respective mRNAs interferes with organizational and activational effects on mating.   
Studies using genetically altered mice in which ERα was knocked out suggest 
that the behaviorally relevant ER is ER-α [112, 129].  We hypothesized that, in the male 
rat MPO and MEA, ER-α is the behaviorally significant form of ER and that selective 
removal of ER-α individually from these brain areas would reduce mating behavior.  We 
tested this hypothesis by bilateral chronic infusion an antisense ODN complementary to 
the start translation site of ER-α mRNA locally into the MPO or the MEA, to knockdown 
the expression of ER-α and monitored changes in copulatory behavior.   
 
EXPERIMENTAL PROCEDURES 
Animals.   
Male and female Sprague-Dawley rats, at least 90 days of age, were obtained 
from Charles River Laboratories.  Animals were housed in polycarbonate cages, 22 x 44 
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x 18 cm, with free access to food and water in the university vivarium on a 14:10 hour 
reverse light:dark cycle (lights off at 0930 hours).  Males were housed two per cage until 
the day of surgery and thereafter, they were single housed.  Females were housed two per 
cage throughout the study.  All maintenance and surgical procedures were in accordance 
with institutional regulations and with the NIH Guide for the Care and Use of Laboratory 
Animals (NIH Publ. No. 85-23, revised 1985).   
Female rats were anesthetized with isoflurane gas by placing them in a chamber 
with an atmosphere of 4% gas and an oxygen exchange rate of 500 cc per minute and 
transferring them to a nosecone dispensing 2-3% gas at 500 cc per minute oxygen 
exchange rate, ovariectomized and implanted s.c. with a 6 mm Silastic capsule filled with 
crystalline E2.  Thereafter, all females were allowed at least seven days recovery time 
before the start of behavioral testing.  On testing days, females received 1.0 mg 
progesterone s.c. (1mg progesterone/0.2 ml sesame oil) 4-6 hours before being paired 
with males.   
Male rats were screened for sexual behavior in four weekly 30 minute mating 
tests to determine their suitability for inclusion in the study and groups of proven maters 
were matched based on total ejaculation frequency.  These males were assigned to one of 
four groups:  1. MPO AS-ODN (N = 6), 2. MPO SAL (N = 8), 3. MEA AS-ODN (N = 6) 
or 4. MEA SAL (N = 7).   
Each male was anesthetized with isoflurane gas by placing them in a chamber 
with an atmosphere of 4% gas and an oxygen exchange rate of 500 cc per minute and 
transferring them to a nosecone dispensing 2-3% gas at 500 cc per minute oxygen 
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exchange rate and stereotaxically implanted bilaterally with 28 gauge stainless steel, 
ethylene oxide sterilized, cannulae aimed at either the MPO (level skull coordinates: ap = 
-0.5 mm, ml = ± 0.75 mm, dv = -9.0 mm) or the MEA (level skull coordinates: ap = -3.2 
mm, ml = ± 3.5 mm, dv = -9.2 mm) [146].  Each cannula was connected via Tygon 
microbore tubing to an osmotic minipump (Alzet, model 2004) implanted subcutaneously 
in the scapular region.  Minipumps infused either AS-ODN dissolved in physiological 
saline (AS-ODN groups) or physiological saline as a vehicle control (SAL groups) at the 
rate of 0.25μl/hr (6μl/day/cannula) for 28 days.  After 5-7 days surgical recovery, weekly 
30 minute sexual behavior testing resumed for a period of 8 weeks.  Minipumps were 
replaced under anesthesia following the fourth postoperative test.  Upon removal at week 
four and at the end of the study, the minipumps were evaluated to assure there were no 
pump failures; none occurred.   
Antisense Oligodeoxynucleotide Preparation.   
Experimental animals were infused via minipumps with 25-mer ODN sequence 
(5’-GTGAAGGGTCATGGTCATGGTGAGT-3’) antisense to the translation start codon 
for rat ER-α [143].  Lyophilized ODN (6290 μg, Oligos Etc. Inc., Wilsonville, OR) was 
resuspended in 7.548 ml sterile physiological saline and stored in aliquots at -80°C until 
use.  These concentrated aliquots were further diluted before use to a working 
concentration of 1μg/12μl, which was used to fill the pumps for the experimental animals 
(vehicle controls received minipumps containing saline only).  Before implantation, 
minipumps were incubated in sterile saline solution for 48 hours at 37°C for priming.   
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Oligodeoxynucleotide Controls. 
 Following behavioral screening, additional groups of matched males were formed 
for infusion of an ODN control.  In these groups, the MPO or MEA was infused with a 
scrambled sequence (SCRAM1:  5’ – CTCTACACATCGTGGATCGTGACTG – 3’, 
MPO N=5, MEA N=5; SCRAM2:  5’ – CTAGGTCTAGCTGTCCACACGTGAG – 3’, 
MPO N=7) or a missense sequence (MIS:  5’ – GTGTAGGGTTATGGTCATTGTAAGT 
– 3’, MPO N=9).  These altered sequences were not complementary to ER mRNA or any 
other known rat mRNA (GenBank nucleotide-nucleotide similarity BLAST search).  In 
contrast to the AS-ODN infused groups, a majority of the animals in these altered 
sequence groups were found to display physiological or behavioral abnormalities which 
resulted in death or required humane euthanasia.  Therefore, further attempts to develop 
this type of control were abandoned for ethical considerations. 
Sexual behavior tests.   
During preoperative sexual screening and postoperative mating tests, each male 
was paired with a sexually receptive female for 30 minutes in a 22 x 44 x 50 cm testing 
arena under dim red light.  Tests began about 3 hours after lights off.  The following 
behaviors were recorded by observers blind to the experimental status of the animals:  
mount frequency (MF):  the number of mounts without penile penetration; intromission 
frequency; (IF):  the number of mounts with penile penetration; and ejaculation frequency 
(EF):  the number of ejaculations.  We also measured mount latency (ML):  time from the 
beginning of the test until the first mount or intromission occurred or a default of 1800 
sec if no mounts occurred; ejaculation latency (EL):  time from the first mount or 
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intromission until the first ejaculation occurred or a default of 1800 sec if no ejaculations 
occurred; and the post-ejaculatory interval (PEI):  time between the first ejaculation and 
the next mount or intromission or a default of 1800 sec if no additional mounting or 
intromission occurred.   
Histological verification.   
When the testing period was concluded, males were euthanized with an overdose 
of sodium pentobarbital (100 mg/kg i.p.) and perfused transcardially for 5 minutes with 
physiological saline followed by a minimum of 300 ml of a fixative containing 2% 
paraformaldehyde and 0.1% picric acid in 0.1 M phosphate buffer (PB) solution (pH 7.4).  
Skulls were then partially opened and immersed overnight in the same perfusion fixative.  
Brains were removed from skulls the next day and stored in 30% sucrose in 0.1M PB for 
approximately 48 hours.  Coronal frozen brain sections (40 μm) through the diencephalon 
were collected into 0.1 M PB, mounted on clean gel-albumin coated slides, and stained 
with Toluine blue to verify cannula placement.   
Estrogen Receptor Immunocytochemistry. 
Coronal sections from animals in the four groups were processed concurrently 
with the same aliquots of antibodies and immunoreagents and were incubated first in a 
blocking solution containing 5% normal donkey serum (NDS) in 0.1 M phosphate buffer 
(PB), pH = 7.4 for 1 h at room temperature and second with the monoclonal 1D5 anti-ER 
antibody for 48 h at room temperature.  The 1D5 anti-ER antibody (Zymed Laboratories, 
catalogue # 18-7149, lot # 40380301) was used at a concentration of 0.75 μg/ml in a 
solution consisting of 5% NDS in 0.1 M PB.  After three 5-min washes in 0.1 M PB, 
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sections were then incubated for 2 h at room temperature with a donkey antimouse 
biotinylated secondary antibody (Jackson Laboratories, Bar Harbor, ME, code # 715-065-
151, lot # 48672) at a dilution of 1/200 in 0.1 M PB plus 3% NDS.  Sections were then 
washed in three 5-min changes of 0.1 M PB and incubated for 1 h at room temperature in 
an avidin-biotinylated peroxidase complex (Vector Elite Standard ABC kit, catalogue # 
PK-6100, A and B reagents prepared at one tenth the manufacture’s recommended 
concentration).  Following three additional 5 min washes in 0.1 M PB, the sections were 
incubated for 20 min at room temperature in a solution containing 0.2 mg/ml 
diaminobenzidine (Sigma) plus 0.1 μl/ml 30% H2O2 (Sigma) dissolved in 0.1 M PB.   
Statistics.   
 Between-group behavioral data were analyzed by repeated measures (group by 
trial) analysis of variance, followed by post hoc comparisons using the Tukey honestly 
significant differences test at a probability level of 0.05, whereas within-group 
comparisons of preoperative and postoperative changes in behavior were analyzed by 
paired t-tests [69].  The Mann-Whitney U test [133] was used to analyze immuno-
cytochemical data.  Two-tailed probabilities are reported unless otherwise stated. 
 
RESULTS 
Male Sexual Behavior.   
 We tested the hypothesis that chronic AS-ODN infusion would reduce mating by 
observing copulatory behavior.  Highly significant group differences emerged during the 
postoperative period.  Animals that had been infused into the MPO with AS-ODN 
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virtually ceased mating, whereas the animals in the other 3 groups exhibited robust 
mating, as indicated by all behavioral indices on all trials (FIGURE 1).  Specifically, 
during postoperative trials, the 4 groups differed significantly in mount frequency (group 
main effect:  F3,23 = 10.20, p < 0.001, trial main effect F7,161 = 2.13, p < 0.043), 
intromission frequency (group main effect:  F3,23 = 15.47, p < 0.001), ejaculation 
frequency (group main effect:  F3,23 = 6.48, p < 0.003), mount latency (group main effect:  
F3,23 = 6.92, p < 0.002, trial main effect F7,161 = 2.75, p < 0.01), ejaculation latency (group 
main effect:  F3,23 = 8.23, p < 0.001) and the post-ejaculatory interval (group main effect:  
F3,23 = 13.48, p < 0.001).  Prior to surgery, however, the animals in all 4 groups had 
mated robustly and the groups were statistically indistinguishable on intromission 
frequency, ejaculation frequency and the post-ejaculatory interval, although some modest 
but significant differences were noted on mount frequency (group x trial interaction:  F9,69 
= 2.07, p < 0.044), mount latency (group x trial interaction:  F9,69 = 2.49, p < 0.016) and 
ejaculation latency (group x trial interaction:  F9,69 = 2.02, p < 0.049).  Thus, group 
differences manifested mainly during the postoperative trials.   
 In a follow-up analysis, groups MPO SAL, MEA AS-ODN and MEA SAL were 
pooled because post hoc comparisons from the analysis above indicated that these 3 
groups were statistically indistinguishable on every behavioral measure on all 
postoperative trials; the sexual performance of this combined control group was 
subsequently compared with that of animals in the MPO AS-ODN group.  Infusion of the 
MPO with AS-ODN profoundly suppressed mating behavior, whereas robust mating 
behavior was expressed on all postoperative trials by animals in the combined control 
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group, as reflected in all behavioral measures.  Specifically, during postoperative trials, 
the resulting 2 groups differed significantly in mount frequency (group main effect:  F1,25 
= 32.60, p < 0.001; trial main effect:  F7,175 = 2.11, p < 0.040), intromission frequency 
(group main effect:  F1,25 = 46.94, p < 0.001; trial main effect:  F7,175 = 2.07, p < 0.049; 
group x trial interaction:  F7,175 = 3.02, p < 0.005), ejaculation frequency (group main 
effect:  F1,25 = 12.85, p < 0.002), mount latency (group main effect:  F1,25 = 15.21, p < 
0.001; trial main effect:  F7,175 = 2.73, p < 0.010; group x trial interaction:  F7,175 = 2.38, p 
< 0.024), ejaculation latency (group main effect:  F1,25 = 21.31, p < 0.001) and the post-
ejaculatory interval (group main effect:  F1,25 = 39.45, p < 0.001; trial main effect:  F7,175 
= 2.72, p < 0.011).  Subsequently, post hoc comparisons between the 2 groups indicated 
significant differences (p < 0.05) in mount frequency on trials 2, 3, 4, 5, 7 and 8, 
intromission frequency on all trials but the first, ejaculation frequency on trials 3 and 5, 
mount latency on trials 3, 5, 6 and 7, ejaculation latency on trials 3, 5 and 6 and the post-
ejaculatory interval on all trials but the first.   
In the MPO AS-ODN group, for each dependent variable, there was a significant 
decline in sexual performance between the preoperative and postoperative periods.  
Specifically, for mount frequency, comparisons of preoperative performance (averaged 
over 4 preoperative trials) with postoperative performance (averaged over the last 4 
postoperative trials, which represents terminal postoperative performance) indicated that 
mounting declined significantly during the postoperative period (t = 3.18, df = 5, p < 
0.025).  Similarly, comparisons of the same sets of trials indicated that intromission 
frequency declined significantly during the postoperative period (t = 5.37, df = 5, p < 
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0.003), as did ejaculation frequency (t = 2.68, df = 5, p < 0.044), whereas mount latency 
(t = 2. 79, df = 5, p < 0.038), ejaculation latency (t = 3.10, df = 5, p < 0.027) and the post-
ejaculatory interval (t = 3.57, df = 5, p < 0.016) increased significantly.  In marked 
contrast to the deterioration of mating that occurred in the MPO AS-ODN group, between 
the preoperative and postoperative periods, considering the same sets of trials, there were 
no significant changes on any behavioral measure between preoperative and 
postoperative periods in the MPO SAL (infused with saline to the MPO), and MEA AS-
ODN (infused with AS-ODN to the MEA) groups.  Moreover, considering the MEA SAL 
group (infused with saline to the MEA), except that intromission frequency was 
significantly lower postoperatively than preoperatively (t = 4.15,df = 6, p < 0.006), the 
animals in this group also exhibited robust mating both before and after surgery and no 
other behavioral measures differed significantly between the preoperative and 
postoperative periods.   
Estrogen Receptor Immunocytochemistry. 
 We tested the hypothesis that chronic AS-ODN infusion would knockdown ER-α 
expression by performing ER-α ICC.  Infusion of the MPO (FIGURE 2) or MEA 
(FIGURE 3) with AS-ODN resulted in suppression of ER-ir neuronal labeling in the 
MPO or MEA, respectively, whereas saline infusion of either brain area was 
accompanied by appreciable ER-ir labeling.  Specifically, significantly fewer ER-ir 
neurons were detected in the MPO of rats in the MPO AS-ODN group (mean ± standard 
error:  4.88 ± 3.18) than were found in the MPO of rats in the MPO SAL group (20.88 ± 
2.83), U = 1, n1 = 5, n2 = 3, p < 0.036, 1-tail.  Moreover, significantly fewer ER-ir 
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neurons were detected in the MEA of rats in the MEA AS-ODN group (0.00 ± 0.00) than 
were found in the MEA of rats in the MEA SAL group (12.79 ± 5.70), U = 0, n1 = 4, n2 
= 4, p < 0.028.  No significant differences in ER-ir neuronal counts were detected in the 
arcuate nucleus of either the MPO AS-ODN and MPO SAL groups (33.99 ± 10.46 and 
29.17 ± 12.50, respectively) or the MEA AS-ODN and MEA SAL groups (30.54 ± 9.32 
and 58.33 ± 11.14, respectively).   
Cannula Placements.   
Locations of cannula placements to the MPO are indicated in FIGURE 4 and 
those to the MEA in FIGURE 5.  Cannula tips were positioned in or near the medial 
preoptic area or medial amygdala, respectively, in almost all cases in all groups of 
animals.   
 
DISCUSSION 
Chronic bilateral infusions of the MPO with an ODN complementary to the start 
translation site of ER-α mRNA knocked down expression of ER-α and impaired mating 
in gonadally intact male rats, whereas infusions of the MEA also knocked down 
expression of ER-α, but did not impair mating.  Specifically, males in the ODN-MPO 
group exhibited severe deficits in mating compared to vehicle controls or to their 
pretreatment levels, but rats in the ODN-MEA group continued to mate at levels that 
were not significantly different from vehicle controls or their pretreatment levels.  
Because E2 action in these brain areas is crucial for mating [12, 32, 33, 59, 60] and 
because ER-α is reported to be the behaviorally relevant form of ER [112, 129], we 
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hypothesized that the knockdown of ER-α in either brain area would suppress mating.  
This hypothesis was partially supported:  ER-α mediates the responses to E2 in the MPO 
that promote mating behavior, but ER-α is not necessary in the MEA for sexual behavior 
to occur.  These results suggest that the mechanisms by which E2 exerts its effects differ 
in the MPO and MEA, thus suggesting differential actions of E2 in individual brain areas.   
Traditionally, ER has been described as a nuclear [68, 76] and/or cytoplasmic 
protein [10] that upon binding E2 acts as a transcription factor for protein synthesis.  At 
present, there are two known forms of ER, ER-α and ER-β and both are believed to act as 
transcription factors, although some reports differ [25].  The receptors are similar in the 
ligand binding domains [165] but dissimilar enough in homology, binding kinetics and 
transactivation properties that some have suggested that each functions in a unique 
manner [26, 115].  Razandi et al. reported that both receptors arise from a single 
transcript [127] and might be a product of variant splicing.  The receptors dimerize upon 
binding E2 [147], creating homodimers if a single receptor type is present in the target 
cell or homo- and heterodimers if both ER-α and ER-β are present; this may influence 
differential selective transcription.  Recently, a novel form of ER has been described that 
functions to integrate signal transduction pathways [128, 148] and we now know that this 
novel receptor, as well as the classical α and β forms, might be associated with the cell 
surface, causing signaling cascades that might or might not culminate in gene 
transcription.  Because the actions of E2 are complex, studies must be carefully structured 
to define the behaviorally relevant actions of E2; they must address questions such as 
which receptors are behaviorally relevant, how ERs cause cellular responses and where 
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the receptors are found in the target cells.  The results from the present study, together 
with recent reports, allow us to begin to answer these questions:  we conclude that the 
behaviorally relevant ER in the MPO is ER-α.   
Steroids act in conjunction with SRC proteins that enable ligand-bound receptors 
to alter transcriptional activity [5].  Such genomic actions seem to be necessary for 
mating behavior to occur, because infusion of transcription inhibitors attenuates mating 
[93].  It has been suggested that E2 acts on the genome as a “chemical switch” [137] to 
promote the synthesis of enzymes for the production of neurotransmitters or other 
neurochemicals that mediate mating.  Novel approaches are being used to discover the 
mechanism(s) of steroidal action on neurons in vivo.  Infusion of antisense ODNs that 
inhibit transcription by blocking SRCs interfere with brain sexual differentiation [91, 
104], and the activation of sexual behaviors [27, 103].   
Studies with E2 conjugated to Bovine Serum Albumin (BSA-E2) are beginning to 
address the question of where E2 acts at the level of the target cell.  BSA-E2 does not 
enter into the interior of the cell but has been shown to act solely at the cell surface [161], 
thereby stimulating plasma membrane-associated receptors.  When implanted into the 
MPO of castrated, DHT-treated male rats, BSA-E2 maintained mating behavior; 
conversely, mating was attenuated in an identical group that received BSA-E2 implants to 
the MEA, which suggests that (i) E2, acting at the cell surface of MPO neurons, is 
sufficient for the expression of mating behavior and (ii) that E2 acts differently in the 
MPO and MEA.  The results of the present study, together with the BSA-E2 findings, 
suggest that the behaviorally relevant ERs are associated with the cell surface in the MPO 
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and that these ER are ER-α, consistent with reports that the membrane-associated ER is 
some form of ER-α [88, 101, 159].  In view of the likelihood that genomic activation is 
necessary for the behavioral response to E2, there might be at least two ways that E2 can 
activate the genome:  through a classical pathway that involves intracellular ER or 
through a transduction mechanism that is coupled to a plasma membrane-associated ER.  
Future studies need to determine if there is only one or more than one behaviorally 
relevant signaling pathway.  If multiple or parallel pathways exist, do they eventually 
culminate in the same result and can one pathway be substituted for another?   
In conclusion, the major findings from this study are that ER-α mediates the 
sexual response to E2 in the MPO and that E2 acts differently in the MPO and MEA.  
Because we employed bilateral, site specific soft-tissue infusion of ODN (instead of 
intra-ventricular infusion) we can begin to develop a specific model of E2 action.  The 
model is based on three premises taken from the present and other findings:  (i) the 
behavioral response to E2 is mediated in the MPO by ER-α, (ii) ER-α can associate with 
the plasma membrane and (iii) a cell surface action of E2 in the MPO is sufficient for 
mating, therefore, the behaviorally relevant ER in the MPO is a plasma membrane-
associated ER-α.  Although E2 is important in the MEA for male mating to occur, ER-α 
does not mediate this response; instead, an intracellular, non-α ER appears to govern the 
response to E2 in the MEA.   
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FIGURE 1 
Mating behaviors (mean ± standard error of the mean) after AS-ODN or saline (vehicle) 
infusion of the MPO or MEA.  Males infused with vehicle to the MPO or MEA mated 
normally as did rats infused with AS-ODN to the MEA, whereas those receiving AS-
ODN to the MPO virtually ceased mating.  Blackened symbols indicate the trials where 
post hoc statistical comparisons revealed that the MPO AS-ODN group differed 
significantly from the other groups (p < 0.05, two-tailed).   
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FIGURE 2 
1D5 estrogen receptor immunocytochemistry of the medial preoptic area.  Sections 
through the MPO and arcuate nucleus from males in the MPO AS-ODN and MPO Saline 
groups were processed concurrently with the 1D5 anti ER-α antibody.  ER-ir labeling did 
not occur in the MPO of males in the MPO AS-ODN group (top left) but was expressed 
normally in the MPO of males in the MPO Saline group (top right) and in the arcuate 
nucleus in all cases (bottom row) suggesting that infusion of AS-ODN blocked 
expression of ER-α in the MPO.    
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FIGURE 3 
1D5 estrogen receptor immunocytochemistry of the medial amygdala.  Sections through 
the MEA and arcuate nucleus from males in the MEA AS-ODN and MEA Saline groups 
were processed concurrently with the 1D5 anti ER-α antibody.  ER-ir labeling did not 
occur in the MEA of males in the MEA AS-ODN group (top left) but was expressed 
normally in the MEA of males in the MEA Saline group (top right) and in the arcuate 
nucleus in all cases (bottom row) suggesting that infusion of AS-ODN blocked 
expression of ER-α in the MEA.   
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FIGURE 4 
Locations of cannula placements to the medial preoptic area.  Cannula tips were 
positioned in or near the MPO in almost all cases in the MPO AS-ODN and MPO Saline 
groups.   
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FIGURE 5 
Locations of cannula placements in the medial amygdala.  Cannula tips were positioned 
in or near the MEA in almost all cases in the MEA AS-ODN and MEA Saline groups.   
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CHAPTER 2 
 
IMPLANTS OF ESTRADIOL CONJUGATED TO BOVINE SERUM ALBUMIN 
IN THE MALE RAT MEDIAL PREOPTIC AREA PROMOTE COPULATORY 
BEHAVIOR 
 
Gloria G. Huddleston, Jacquelyn C. Paisley and Andrew N. Clancy, Neuroendocrinology 
MS # 200604007, submitted, 2006.  
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ABSTRACT 
The expression of mating behavior in male rats is dependent on estrogen-
responsive neurons in the medial preoptic area (MPO).  Previous reports showed that 
mating is attenuated if the aromatization of testosterone to estradiol (E2) is blocked in the 
MPO [32] and that mating is maintained by MPO E2 implants [33].  However, the 
mechanisms by which E2 exerts its action are not fully understood.  It had been thought 
that E2 acted exclusively by binding to nuclear estrogen receptors to exert it effects; 
however, recent reports suggest that E2 also binds to membrane-associated receptors 
activating downstream intracellular cascade responses.  In this study, we asked if an 
action of E2 at the cell surface is sufficient to support mating behavior.  Therefore, either 
vehicle, E2, or E2 conjugated to Bovine Serum Albumin (BSA-E2:  a complex of E2 and a 
large protein that will not cross the plasma membrane, thereby restricting the action of E2 
to cell-surface signaling) was chronically administered bilaterally to the MPO of 
castrated, dihydrotestosterone-treated male rats.  Mating behavior was supported by MPO 
BSA-E2 implants, suggesting that E2 operates in the MPO via a cell-surface mechanism 
to facilitate male rat mating behavior.   
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INTRODUCTION 
In mammals, gonadal hormones act on both central and peripheral structures to 
promote mating.  Testicular testosterone (T) may be converted enzymatically in target 
tissues into at least two metabolites: dihydrotestosterone (DHT) via 5-alpha reductase 
[90] and estradiol (E2) via aromatase [108].  These metabolites, and probably T itself, 
maintain peripheral sexual organs; moreover, their actions on steroid sensitive central 
neurons are necessary for male sexual behavior to occur [151].  It is likely that these 
central neurons form a pathway or network in the male rat brain [43] analogous to the 
pathway governing the lordotic reflex in female rats [41, 119].  Under the influence of 
steroids, this pathway transduces or enables the integration of motivational stimuli and 
the execution of mating.   
In every vertebrate species studied to date, a functional response to gonadal 
steroids takes place in the medial preoptic area (MPO) that is essential for male 
reproductive behavior to occur.  The MPO receives processes and integrates sexually 
relevant inputs [134] and transmits information to brain areas that regulate autonomic, 
somatomotor and motivational states necessary for mating [136].   Both electrolytic [28, 
78, 80] and chemical [56, 80] lesions of the MPO result in severe deficits in male mating, 
as do strategically placed knife cuts severing efferent pathways of the MPO [14, 86].  
Electrophysiological studies of MPO neurons have shown increased activity in response 
to T [120, 175] and E2 [17, 65], and it has been shown that both androgens [96], and E2 
[44] are required for robust mating behavior.  Supporting these ideas, Greco et al., 
showed that mating-induced Fos-ir (the protein product of the c-fos gene, an accepted 
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marker of metabolic activity in neurons [131]) is colocalized in neurons with androgen 
receptors (AR), estrogen receptors (ER) or both receptor types in brain areas known to 
contribute to the expression of male mating behavior, including the MPO, medial 
amygdala (MEA), bed nucleus of stria terminalis, and central tegmental field [51].  
Hormone manipulations within these areas can modify sexual responses and compromise 
the functioning of the purported neural network that governs male mating behavior.   
In studying the effect(s) of E2 on neurons in this network, we showed that 
systemic administration of Fadrozole (CGS-16949A CIBA-Geigy Corporation, Summit, 
NJ), a non-steroidal aromatase enzyme inhibitor that blocks the conversion of T to E2, 
results in severe copulatory deficits in castrated, T-maintained male rats, which 
exogenous E2 partially reverses [12].  Local administration of Fadrozole to the MPO of 
intact males significantly attenuates mating but vehicle MPO implants do not [32].  
Conversely, intact males given systemic Fadrozole and MPO vehicle implants suffer 
severe deficits of mating, whereas those receiving MPO E2 implants continue to mate 
[33].   
Clearly, the presence of E2 in the MPO of male rats is crucial for the display of 
mating behavior; the mechanism of E2 action(s), however, is less well understood.  
Traditionally, it had been believed that E2 either binds to a cytoplasmic receptor that 
translocates to the nucleus or to an intranuclear receptor, ultimately interacting with DNA 
and serving as a transcription factor for the production of protein products via mRNA 
synthesis [64, 68, 164].  Infusion of transcription inhibitors attenuates mating [93], as 
does infusion of antisense oligonucleotides targeting steroid receptor co-activators [27], 
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suggesting the necessity of a genomic response to E2.  Although reports of rapid effects 
of E2 on neurons and cells of other tissue have been long been reported [102, 121], a 
plethora of recent reports, as well as reports of a novel G-protein membrane-associated 
ER [128, 148], imply that rapid cellular responses may result from E2 binding to 
membrane-associated receptors (mER).  Though some differences between reports 
remain, it is generally accepted that rapid effects of E2 have been shown, as demonstrated 
by intracellular increases of phosphorylated CREB [180], phosphorylated MAPK [161], 
cAMP [102], calcium [21, 24], or other pathways, as well as changes in membrane 
permeability [77, 121], and it is believed that these rapid effects might [180] or might not 
[77] involve genomic action.  There are differing theories as to the nature of these mERs:  
(i) they might or might not be inserted into, or tethered to, the plasma membrane, (ii) they 
might aggregate at its inner surface or (iii) they might shuttle from the cytoplasm to the 
plasma membrane in the presence of E2.  These ideas raise questions about how E2 acts.  
Is a surface action of E2 sufficient to cause physiological responses that affect behavior, 
or must E2 act intracellularly to have an effect on behavior, or both?  We hypothesized 
that E2 must penetrate fully into the interior of target MPO neurons to promote mating in 
castrated, DHT-treated male rats.   
In order to test this hypothesis, in this study we compared the behavioral effects 
of delivering either E2 or E2 conjugated to bovine serum albumin (BSA-E2) to the MPO 
in castrated, DHT-maintained male rats.  Bovine Serum Albumin (BSA) is a large protein 
that will not cross the plasma membrane and, when conjugated to steroids, can be used to 
isolate responses to steroids that are confined exclusively to the cell surface [117].  We 
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predicted that stimulation of MPO mER alone by BSA-E2 would be insufficient to 
maintain mating behavior, whereas stimulation of all ER by E2 would support normal 
mating.   
 
EXPERIMENTAL PROCEDURES 
Animals.  Male and female Sprague-Dawley rats, at least 70 days of age, were 
obtained from Charles River Laboratories. Animals were housed in plastic cages, 22 x 44 
x 18 cm, with free access to food and water in the university vivarium on a 14:10 hour 
reverse light:dark cycle (lights off at 0930 hours).  Males were housed two per cage until 
the day of surgery; thereafter, they were singly housed.  Females were housed two per 
cage throughout the study.  All husbandry and surgical procedures were performed with 
permission of the IACUC and with the NIH Guide for the Care and Use of Laboratory 
Animals (NIH Publ. No. 85-23, revised 1985).   
 Female rats were anesthetized with isoflurane gas by placing them in a chamber 
with an atmosphere of 4% gas and an oxygen exchange rate of 500 cc per minute and 
transferring them to a nosecone dispensing 2-3% gas at 500 cc per minute oxygen 
exchange rate, ovariectomized, and a subcutaneous (s.c.) 6 mm Silastic (Dow Corning, 
Midland, MI) capsule (1.981 mm id X 3.175 mm od) filled with crystalline E2 (Sigma, St. 
Louis, MO) was implanted in the scapular region.  Thereafter, all females were allowed 
at least seven days to recover before the start of behavioral testing.  On testing days, to 
induce estrus behavior, females received an injection of 1.0 mg progesterone in 0.2 ml 
sesame oil s.c. 4-6 hours before being paired with males.   
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 Male rats were screened for sexual behavior in four weekly 30 minute mating 
tests to determine their suitability for inclusion in the study.  Based on total ejaculation 
frequency, proven maters were assigned to three matched groups:  (i) BSA-E2 (N = 9, to 
limit E2 action to the cell surface), (ii) free E2 (N = 7, to simulate ER in all cellular 
locations) or (iii) vehicle (N = 8, inert control).  Each male was anesthetized with 
isoflurane gas by placing them in a chamber with an atmosphere of 4% gas and an 
oxygen exchange rate of 500 cc per minute and transferring them to a nosecone 
dispensing 2-3% gas at 500 cc per minute oxygen exchange rate, castrated and implanted 
s.c. with a 10 mm Silastic capsule (1.981 mm id X 3.175 mm od) containing crystalline 
DHT (Sigma).  DHT capsules of this size have been reported to produce circulating DHT 
levels in the physiological range [3, 82, 118].  Thereafter, they were stereotaxically 
implanted bilaterally with 22 gauge, stainless steel, ethylene oxide sterilized, guide 
cannulae (Plastics One, Roanoke, Virginia) aimed at the MPO (level skull coordinates: ap 
= -0.5 mm, ml = ± 0.75 mm, dv = -8.0 mm [146]).  Inner cannulae (28 gauge, Plastics 
One) extended 1 mm below the guide cannulae and were tamped in either:  (i) 1,3,5(10)-
estratrien-3, 17β-diol 17-hemisuccinate:BSA (Steraloids, Inc., Newport, Rhode Island, 
code E1077-000; BSA-E2), (ii) a 1:40 (wt/wt) mixture of unconjugated, crystalline E2 
(Sigma) plus unconjugated, crystalline BSA (Sigma; free-E2) or (iii) a 1:40 (wt/wt) 
mixture of unconjugated, crystalline cholesterol (Sigma) plus unconjugated, crystalline 
BSA (vehicle), sterilized and inserted into the guide cannulae.  Males were given five to 
seven days to recover before the weekly postoperative behavioral testing began.  Freshly 
tamped sterilized inner cannulae were inserted into the brain 48 hours before and 24 
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hours after every behavioral test.  In a group of pilot animals, daily microscopic 
inspection of cannula tips for crystalline material ensured that this replacement schedule 
would continuously expose the brain to the appropriate agent.   
Sexual behavior tests.  During preoperative sexual screening and postoperative 
mating tests, each male was paired with a sexually receptive female for 30 minutes in a 
22 x 44 x 50 cm testing arena under dim red light.  Tests of this duration are sufficiently 
long for male rats to obtain multiple ejaculations with females, and a 30 minute test 
length is also used by other investigators [15].  Tests began 3 hours after lights went off 
for the day.  The following behaviors were recorded by observers blind to the 
experimental status of the animals:  mount frequency (MF) - the number of mounts 
without penile penetration; intromission frequency; (IF) - the number of mounts with 
penile penetration; and ejaculation frequency (EF) - the number of ejaculations.  We also 
measured mount latency (ML) - time from the beginning of the test until the first mount 
or intromission occurred or a default of 1800 sec if no mounts occurred; ejaculation 
latency (EL) - time from the first mount or intromission until the first ejaculation 
occurred or a default of 1800 sec if no ejaculations occurred; and the post-ejaculatory 
interval (PEI) - time between the first ejaculation and the next mount or intromission or a 
default of 1800 sec if neither occurred.   
Histological verification.  When the testing period was concluded, males were 
euthanized with an overdose of sodium pentobarbital (100 mg/kg i.p.) and perfused 
transcardially for 5 minutes with physiological saline followed by a minimum of 300 ml 
of a fixative containing 2% paraformaldehyde and 0.1% picric acid in 0.1 M phosphate 
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buffer (PB) solution (pH 7.4).  Skulls were partially opened and immersed overnight in 
perfusion fixative.  Brains were removed from skulls the next day and stored in 30% 
sucrose in 0.1 M PB for approximately 48 hours.  Frozen coronal brain sections (40 μm) 
through the diencephalon were collected into 0.1 M PB, mounted on clean gel-albumin 
coated slides, and stained with Toluine blue to verify cannula placement.   
Estrogen receptor immunocytochemistry.  The H222 monoclonal anti-ER 
antibody (generous gift of Dr. Geoffrey Greene) was used at a concentration of 10 μl/ml.  
Coronal 40 μm MPO sections from animals in the three groups were processed 
concurrently with the same aliquots of antibodies and immunoreagents and were 
incubated first in a blocking solution containing 3% normal goat serum for 48 h at 4o C 
and second with the H222 anti-ER antibody for 48 h at 4o C.  After three 5-min washes in 
0.1 M PB, sections were then incubated for 2 h at room temperature with a biotinylated 
goat antirat secondary antibody (Jackson Laboratories, Bar Harbor, ME, code # 112-065-
062, lot # 30138) at a dilution of 1:500.  Sections were then washed in three 5-min 
changes of 0.1 M PB and incubated for 1 h at room temperature in an avidin-biotinylated 
peroxidase complex (Vector Elite Standard ABC kit, A and B reagents prepared at ½ the 
manufacture’s recommended concentration).  Following three additional 5 min washes in 
0.1 M PB, the sections were incubated for 10 min at room temperature in a solution 
containing 0.2 mg/ml diaminobenzidine (Sigma) plus 0.1 μl/ml 30% H2O2 (Sigma) 
dissolved in 0.1 M PB.   
 Statistics.  Between-group behavioral data were analyzed by one-way or repeated 
measures (group by trial) analysis of variance, followed by post hoc comparisons using 
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the Tukey honestly significant differences test at a probability level of 0.05 [69].  Within-
group comparisons of preoperative and postoperative changes in behavior were analyzed 
by paired t-tests [69].  Data from all males were used in the statistical analyses; default 
values (see sexual behavior tests) were used in situations where animals did not display a 
given behavior.  Two-tailed probabilities are reported in all cases.   
 
RESULTS 
 Male Sexual Behavior.  Highly significant group differences emerged during the 
postoperative period.  Animals receiving either BSA-E2 or free E2 in the MPO exhibited 
more robust mating behavior than vehicle controls on all behavioral indices and trials 
(FIGURE 6).  Specifically, during postoperative trials, the groups differed significantly in 
mount frequency (group main effect:  F2,21 = 11.04, p < 0.001), intromission frequency 
(group main effect:  F2,21 = 8.99, p < 0.002), ejaculation frequency (group main effect:  
F2,21 = 12.89, p < 0.001), mount latency (group main effect:  F2,21 = 22.14, p < 0.001), 
ejaculation latency (group main effect:  F2,21 = 15.17, p < 0.001) and the post-ejaculatory 
interval (group main effect:  F2,21 = 16.57, p < 0.001).  Prior to surgery, however, the 
animals in all three groups had mated robustly and the groups did not differ significantly 
on any measure.  Thus, all group differences manifested during the postoperative trials.   
 In a follow-up analysis, to compare the effects of E2 versus vehicle, the two 
groups implanted in the MPO with either BSA-E2 or free E2 were pooled because post 
hoc comparisons from the analysis above indicated that they were statistically 
indistinguishable on every behavioral measure on all postoperative trials.  The sexual 
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performance of this pooled estrogen group was subsequently compared with that of the 
vehicle controls.  Both types of estrogen implants to the MPO promoted mating behavior, 
whereas vehicle implants did not maintain sexual behavior.  Specifically, during 
postoperative trials, the pooled estrogen group performed significantly better than the 
vehicle group in mount frequency (group main effect:  F1,22 = 20.12, p < 0.001), 
intromission frequency (group main effect:  F1,22 = 17.56, p < 0.001), ejaculation 
frequency (group main effect:  F1,22 = 19.97, p < 0.001), mount latency (group main 
effect:  F1,22 = 40.39, p < 0.001), ejaculation latency (group main effect:  F1,22 = 26.27, p 
< 0.001) and the post-ejaculatory interval (group main effect:  F1,22 = 32.41, p < 0.001).  
Subsequently, post hoc comparisons between the pooled estrogen and vehicle groups 
indicated significant increases (p < 0.05) in mount frequency on trials 2, 3 and 4; 
intromission frequency on trials 3 and 4; and ejaculation frequency on trials 2, 3 and 4; 
also, significant group decreases (p < 0.05) were observed in mount latency, ejaculation 
latency and the post-ejaculatory interval on all postoperative trials.   
The behavior of each group was examined for changes during the preoperative 
and postoperative periods.  In the BSA-E2 group, for each dependent variable, there were 
no significant changes in mating behavior between the preoperative and postoperative 
periods.  Specifically, no significant differences were noted between scores on the fourth 
preoperative test (representing terminal preoperative performance) and those on the last 
postoperative trial (representing terminal postoperative performance).  Although mount 
frequency and intromission frequency scores in the free E2 group were significantly lower 
on the fourth postoperative test compared to the fourth preoperative trial (t = 3.47, df = 6, 
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p < 0.01 and t = 4.17, df = 6, p < 0.005, respectively), most animals in this group 
nevertheless mated to ejaculation with females on both of these tests, and, with respect to 
ejaculation frequency, mount latency, ejaculation latency and the post-ejaculatory 
interval, scores did not differ significantly before and after surgery.  In contrast, sexual 
performance in the vehicle control group deteriorated significantly after surgery.  
Specifically, mount frequency (t = 5.29, df = 7, p < 0.001), intromission frequency (t = 
12.42, df = 7, p < 0.001) and ejaculation frequency (t = 4.71, df = 7, p < 0.002) decreased 
significantly between the last preoperative test and the fourth postoperative trial, and 
mount latency (t = 8.82, df = 7, p < 0.001), ejaculation latency (t = 4.91, df = 7, p < 
0.002) and the post-ejaculatory interval (t = 4.61, df = 7, p < 0.002) increased 
significantly between the last preoperative test and the fourth postoperative trial.   
 Cannula Placements.  Locations of cannula placements are indicated in FIGURE 
7.  Cannula tips were positioned in or near the medial preoptic area in all groups of 
animals.   
 H222 Estrogen Receptor Immunoreactivity.  H222 ER ICC was performed to 
test the integrity in vivo of the bond between E2 and BSA.  Neurons near the cannula 
tracts and ependymal zone of the MPO were positively labeled for H222 ER-ir in both 
the vehicle and BSA-E2 groups suggesting that intracellular ERs were not occupied by 
E2.  Conversely, no H222 ER-ir was seen in the free E2 group indicating that E2 had 
penetrated the cell membrane to bind to intracellular ERs (FIGURE 8).   
 
 
 47
DISCUSSION 
 In this study we used MPO implants to compare the efficacy of free E2 and BSA-
E2, a membrane-impenetrant form of E2, to support mating in castrated, DHT-maintained 
male rats.  We found that BSA-E2 and free E2 were equally effective at maintaining 
copulatory behavior at significantly higher levels than did vehicle (which was ineffective 
in promoting mating behavior).  This did not support our hypothesis that E2 must 
penetrate fully into the interior of target MPO neurons to promote mating in castrated, 
DHT-treated male rats.  Instead, these findings show that E2 stimulation of mER is 
sufficient to promote mating and raise several questions regarding the mechanisms of E2 
action, the nature of the receptor, the roles of intracellular ER, and the differential effects 
of E2 in various brain areas.  Although the present data do not resolve all of these issues, 
the findings nevertheless support the ideas that stimulation of mER results in 
physiological [75, 138] and behavioral [42, 47] responses in vivo.   
 BSA-E2 and free E2 were equally effective in promoting mating (whereas the 
vehicle was ineffective) suggesting that stimulation of mER alone is sufficient for the 
display of male copulatory behavior.  An earlier study [116] showed that blocking 
expression of ER-α in the MPO by chronic infusion of an antisense oligodeoxynucleotide 
(ODN) to ER-α mRNA attenuates mating.  This is consistent with other reports 
suggesting that ER-α is the relevant ER for male mating behavior [123, 162].  Together, 
these findings imply that some form of ER-α operates as an mER, an idea that is further 
strengthened by Khan et al. [67] showing colocalization of ERα and MNAR/PELP1 (a 
scaffold protein and ER cofactor) at the plasma membrane of rat MPO neurons.   
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 Although stimulation of ER-α in the MPO appears to be sufficient to induce 
mating behavior in DHT-maintained rats, it is interesting to note that this is not the case 
in the MEA.  Blocking expression of ER-α in the MEA via antisense ODN infusion did 
not attenuate male mating behavior [116], suggesting that either ER-β or some novel 
form of ER, such as those described by Revankar and Thomas [128, 148], might mediate 
the actions of E2 in the MEA.  Moreover, in contrast to this study, administration of BSA-
E2 to the MEA of castrated, DHT-maintained males did not maintain mating behavior 
[60].  Thus, taken together, these results suggest differential actions of E2 in different 
brain areas, perhaps via alternative receptor mechanisms.   
These interpretations depend on the stability of BSA-E2 in the brain.  Published 
studies have successfully used BSA conjugated to steroids to investigate the rapid or 
membrane-limited signaling of hormones [22, 24, 47, 117, 161], and the use of such 
conjugates has become an accepted research method.  Watters et al. [161] showed that 
BSA-E2 does not cleave while it promotes cellular responses in vitro [180], although the 
action of an endogenous enzyme in vivo cannot be ruled out.  We inferred that cleavage 
of the bond between E2 and BSA does not occur in the rat brain because identical doses 
and aliquots of BSA-E2, when administered to the MEA, did not maintain mating [60].  
As in the MPO, free E2 acts in the MEA to promote male sexual behavior [59] and, if 
cleavage of E2 from BSA-E2 had occurred, then rats with BSA-E2 MEA implants should 
have mated, but they did not.  To confirm that E2 does not cleave from BSA-E2 in vivo, in 
this study we used the H222 anti-ER antibody, which was raised in rat against full-length 
ER and recognizes the steroid-binding domain of human ER [55].  Previous studies 
 49
showed that the presence of E2 interferes with H222 ER-ir labeling, whereas neurons are 
H222 ER-ir positive when E2 is absent [6, 30].  Neurons were H222 ER-ir negative in 
MPO sections from the free E2 group but were H222 ER-ir positive in the vehicle and 
BSA-E2 groups, which argues that cleavage of the bond between E2 and BSA had not 
occurred.   
ER was initially described as a cytosolic protein that, upon binding E2, 
translocated to the nucleus to induce mRNA transcription and protein translation.  In 
1997, a second ER was discovered in rat prostatic tissue [76], described as ER-β (the 
original ER is now referred to as ER-α).  ER-β was also described as a nuclear 
transcription factor, although there are reports to the contrary [25, 176].  As early as 
1977, Pietras suggested that an alternative ER associated with the cellular plasma 
membrane facilitated the rapid (seconds or minutes) effects of E2 [121].  In recent years, 
reports of rapid effects of E2, assumed to be mediated by mER, have increased 
substantially in number.  Studies investigating these rapid cellular responses have raised 
complex issues that have yet to be resolved.  For example, there is a consensus that these 
mERs mediate signal transduction events that, via kinase activation [24, 102, 161, 180], 
conformational changes in ion channels [66], or other mechanisms [21], lead to a rapid 
cascade of cellular responses, which, until recently, were thought of as non-genomic 
events.  “Classical” action(s) of steroids has been defined as transcription events 
occurring in the nucleus and “non-genomic” action(s) of steroids has referred to rapid 
events that are presumed to be mediated by membrane-associated receptors.  We now 
know that rapid effects of E2 can also culminate in gene transcription [160] but do not 
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always do so [77].  Researchers must first address the confusions that arise from the use 
of terms such as “rapid”, “non-genomic” and “genomic” effects.  Second, they must 
reach a consensus on the nature of the mER.  Several reports suggest that alternative 
form(s) of ER-α may serve as the mER [34, 88, 155], but a small number of reports 
suggest that ER-β may function as an mER [25, 76].  Third, the manner in which mERs 
are associated with cell membranes is not fully understood.  There are reports that mER 
has no extracellular domain [46, 142] or glycosylation [88], which suggests that mERs lie 
adjacent to the membrane but are not inserted into it.  Conversely, some reports suggest 
that proteins couple ER to the plasma membrane [81].  Fourth, to further complicate 
matters, many reports have originated from in vitro studies of various tumor cell lines 
that do not normally express ER, but have been transfected to express them and in some 
cases these ER-negative cells (without endogenous ER) nevertheless respond to E2, 
suggesting either a non-receptor mechanism or an undescribed ER [109].   
Our study does not address the question of whether E2 acts "classically" or "non-
genomically" (or both) because our implants were chronic.  It does show, however, that 
in the MPO, confining E2 exclusively to the cell surface maintains male rat mating 
behavior.  Because cell surface actions of E2 can activate multiple signaling pathways, 
including genomic responses, more investigations are needed to determine the cellular 
mechanisms that influence mating.  Nevertheless, these finding extend previous reports 
showing that rodents respond quickly to gonadal steroids by exhibiting mating-associated 
behaviors [42, 47] and also support the idea that steroids act differently in different brain 
areas [116].  Because a membrane impenetrant form of E2 maintained mating, we 
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conclude that a cell surface action of E2 in the MPO is sufficient for expression of male 
sexual behavior.   
 
ACKNOWLEGEMENTS 
This work partially fulfills the Doctor of Philosophy degree requirements of the 
Department of Biology, Georgia State University for G. G. Huddleston and was 
supported by National Science Foundation grant IBN 9876754 to the Center for 
Behavioral Neuroscience.  We thank Dr. Geoffrey Greene for kindly donating the H222 
anti-ER antibody, Dr. Laura Carruth for critically reviewing the manuscript and Ms. 
Donna Beauford for expert technical assistance.   
 
 52
FIGURE 6 
Mating behaviors (mean ± standard error of the mean) after BSA-E2, BSA + E2 (free E2) 
or BSA + cholesterol (vehicle) implants to the MPO.  Males implanted with vehicle to 
the MPO (squares) virtually ceased mating, whereas those implanted with either form of 
E2 (gray circles or triangles) mated robustly.  Relative to vehicle controls, the pooled 
estrogen group showed significantly more mounts, intromissions and ejaculations and 
mount latency, ejaculation latency and the post ejaculatory interval were significantly 
shorter.  Blackened squares indicate the trials where post hoc statistical comparisons 
revealed that the vehicle group differed significantly from the pooled estrogen group (p < 
0.05, two-tailed).   
* Significant within-group difference between the last postoperative trial and the last 
preoperative (PRE-) trial (p < 0.005, two-tailed).   
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FIGURE 7 
Locations of cannula tips in animals implanted with BSA-E2 to the MPO (left), BSA + E2 
(free E2; center) or BSA + cholesterol (vehicle; right).  Cannula tips were positioned in or 
near the medial preoptic area.   
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FIGURE 8 
H222 ER-ir immunoreactivity in the MPO.  In MPO sections from the BSA-E2 group 
(left panel) and the vehicle group (right panel) neurons near the implant tracts and 
ependymal zone exhibited H222 ER-immunoreactivity but no labeled neurons were 
found in the free E2 group (center panel).  Scale bar equals 25 μm.   
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CHAPTER 3 
 
EFFECTS OF ESTROGEN IN THE MALE RAT MEDIAL AMYGDALA:  
INFUSION OF AN AROMATASE INHIBITOR LOWERS MATING AND 
BOVINE SERUM ALBUMIN CONJUGATED-ESTRADIOL IMPLANTS DO 
NOT PROMOTE MATING 
 
Gloria G. Huddleston, Jacquelyn C. Paisley and Andrew N. Clancy, Neuroendocrinology, 
83, 106-116, 2006. 
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ABSTRACT 
In male rats, copulatory behavior depends on estrogen-responsive neurons located 
in brain areas known to be crucial for mating.  Blocking the aromatization of testosterone 
(T) to estradiol (E2) either throughout the brain or within the medial preoptic area (MPO) 
reduces mating, whereas E2 treatment of either the MPO or the medial amygdala (MEA) 
maintains sexual behavior.  The effects of T aromatization in the MEA have received less 
attention; therefore, two studies were done to further elucidate the effects of E2 in the 
MEA.  In Experiment 1, gonadally intact male rats that showed robust mating behavior 
were administered chronic Fadrozole, a non-steroidal aromatase inhibitor, to the MEA to 
stop the conversion of T to E2 and then paired with receptive females.  Infusion of 
Fadrozole to the MEA significantly lowered mating behavior in experimental males 
compared to vehicle-infused control males.  To further investigate the mechanism by 
which E2 acts in the MEA, in Experiment 2, E2-conjugated to Bovine Serum Albumin 
(BSA-E2:  a complex of E2 and a large protein that will not cross the plasma membrane, 
thereby restricting the action of E2 to cell-surface signaling) was chronically administered 
bilaterally to the MEA of castrated, dihydrotestosterone-treated males.  This treatment 
did not maintain mating behavior.  These studies show E2 acts in the MEA to promote 
male sexual behavior and suggest an intracellular mechanism of E2 action.   
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INTRODUCTION 
 Mammalian male mating behavior depends on the actions of gonadal steroids on 
both central and peripheral structures.  Testicular testosterone (T) is converted both 
peripherally and centrally to dihydrotestosterone (DHT) by 5-alpha reductase [90] and to 
estradiol (E2) by aromatase [108].  Both metabolites, and T itself, interact to regulate 
male mating [151].  In female rats, receptivity (evidenced by lordosis) is mediated by an 
interconnected neuronal network composed of steroid-responsive (estrogen-responsive) 
cells [41, 119].  Presumably, a similar steroid-activated system or pathway governs the 
display of male copulatory behavior, an idea supported by the presence of estrogen 
receptors (ER) and/or androgen receptors (AR) colocalized with mating-induced Fos-ir in 
neurons of the medial preoptic area (MPO), the medial amygdala (MEA), the central 
tegmental field, the bed nucleus of the stria terminalis, and other areas known to mediate 
mating behavior [51].   
The MPO is a brain area that is critical for the expression of male copulatory 
behavior.  Electrical [28, 78] or chemical [56] lesions of the MPO attenuate male mating; 
and, conversely, electrical [87, 153] or chemical [43, 44] stimulation promotes it.  We 
have previously shown the behavioral importance of E2-responsive neurons of the MPO 
in studies using a non-steroidal aromatase enzyme inhibitor, Fadrozole, to block the 
conversion of T to E2.  Subcutaneous (s.c.) administration of Fadrozole significantly 
decreased the conversion of [3H]T to [3H]E2 in male rat hypothalamic and amygdaloid 
nuclear fractions [12].  Moreover, administering Fadrozole s.c. (but not vehicle) to 
castrated, T-maintained male rats significantly decreased mating behavior, and 
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subsequent administration of E2 partially restored some copulatory behaviors [12].  
Chronic intracranial infusion of Fadrozole (but not saline) bilaterally to the MPO also 
significantly decreased mating [32].  Conversely, mating behavior was maintained in rats 
given chronic Fadrozole s.c. (to block T aromatization throughout the brain) together 
with bilateral MPO implants of E2 (but not vehicle) [33].  Anatomical controls showed 
that Fadrozole is not toxic to the brain and does not interfere with behaviors, with the 
exception of those that are dependent on the estrogenic metabolites of T [32].   
The MEA, a limbic site that is reciprocally connected to the MPO [18, 41, 136], 
receives chemosensory [37], genital-somatosensory [8, 52] and other projections 
necessary for male sexual behavior and also contains ER [51].  Because mating-induced 
Fos-ir is colocalized with ER in neurons of the MEA, the same experimental approach 
(chronic Fadrozole s.c. plus bilateral intracranial E2 implants) that proved useful in our 
previous investigation on the effect of E2 in the MPO was used to determine the effects of 
E2 in the MEA.  Male rats receiving Fadrozole s.c. and vehicle implants to the MEA 
showed significant reductions in mounting, intromission and ejaculation; however, males 
receiving Fadrozole s.c. and bilateral E2 implants to the MEA mounted and intromitted at 
levels that were not significantly different from presurgical levels, although ejaculation 
was not maintained [59].  These findings suggest that estrogen-responsive MEA neurons 
contribute to male sexual behavior.  To test this hypothesis, we performed, in Experiment 
1, the opposite manipulation:  Fadrozole was chronically administered bilaterally to the 
MEA of sexually experienced, gonadally intact male rats.  We predicted this would 
deprive the MEA of E2 aromatized from T and significantly lower male mating behavior.   
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 The mechanism(s) by which E2 exerts its effects on neurons is poorly understood.  
Traditionally, it had been thought that E2 functioned only as a selective transcription 
regulator of DNA [64].  We now know that there is a diversity of ERs in various cellular 
locations.  ERs have been described in the nucleus [68, 76], the cytoplasm [10], tethered 
to intracellular membranes [100, 101, 128, 176], and both classical [25, 121, 122, 155] 
and novel [128, 148] forms of ER have been described as being associated with the 
plasma membrane.  Non-nuclear ERs are believed to mediate rapid effects of E2 (seconds 
to minutes) by activating cellular signaling cascades that might or might not culminate in 
gene transcription.  This raises questions as to whether E2 acts at the cell surface, 
intracellularly or both.  Previous studies have used either progesterone [47] or E2 [117] 
conjugated to Bovine Serum Albumin (BSA), a large protein that does not cross the 
plasma membrane [125], to limit the effects of hormone to the membrane.  We 
hypothesized that E2 would act at the plasma membrane in the MEA to maintain mating 
behavior.  Therefore, in Experiment 2, E2 conjugated to BSA (BSA-E2) was chronically 
administered bilaterally to the MEA of sexually experienced, castrated, DHT-maintained 
male rats, which we anticipated would maintain mating.   
 
MATERIALS AND METHODS 
Animals.  Male and female Sprague-Dawley rats, at least 70 days of age, were 
obtained from Charles River Laboratories. Animals were housed in plastic cages, 22 x 44 
x 18 cm, with free access to food and water in the university vivarium on a 14:10 hour 
reverse light:dark cycle (lights off at 0930 hours).  Males were housed two per cage until 
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the day of surgery; thereafter, they were single housed.  Females were housed two per 
cage throughout the study.  All maintenance and surgical procedures were in accordance 
with institutional regulations and with the NIH Guide for the Care and Use of Laboratory 
Animals (NIH Publ. No. 85-23, revised 1985).   
 Female rats were anesthetized with isoflurane gas by placing them in a chamber 
with an atmosphere of 4% gas and an oxygen exchange rate of 500 cc per minute and 
transferring them to a nosecone dispensing 2-3% gas at 500 cc per minute oxygen 
exchange rate, ovariectomized and given s.c. a 6 mm Silastic capsule (1.981 mm id X 
3.175 mm od) filled with crystalline E2.  Thereafter, all females were allowed at least 
seven days to recover before the start of behavioral testing.  On testing days, females 
received 1.0 mg progesterone in 0.2 ml sesame oil s.c. 4-6 hours before being paired with 
males.   
 Male rats were screened for sexual behavior in four weekly 30 minute mating 
tests to determine their suitability for inclusion in the study; and in each experiment, 
groups of proven maters were matched based on total ejaculation frequency.  In the first 
study, males were assigned to one of two groups: Fadrozole-in-MEA or Saline-in-MEA.  
In the second study, males were assigned to one of two groups:  BSA-E2-in-MEA or 
cholesterol-in-MEA.   
Experiment 1:  Fadrozole and saline administration to MEA. Each male was 
anesthetized with isoflurane gas by placing them in a chamber with an atmosphere of 4% 
gas and an oxygen exchange rate of 500 cc per minute and transferring them to a 
nosecone dispensing 2-3% gas at 500 cc per minute oxygen exchange rate and 
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stereotaxically implanted bilaterally with 25 or 28 gauge stainless steel, ethylene oxide 
sterilized cannulae (Plastics One, Roanoke, Virginia) aimed at the MEA (level skull 
coordinates: ap = -3.2 mm, ml = ± 3.5 mm, dv = -9.2 mm [146]) and connected via tubing 
to an osmotic minipump (ALZET models 2002 or 2004).  In the saline group (n = 11), 
cannulae delivered 6 μl sterile isotonic saline per 24 hrs to each side of the brain.  In the 
Fadrozole group (n = 9), cannulae delivered 0.80 - 1.38 μg Fadrozole (CGS-16949A, 
CIBA-Geigy Corporation, Summit, NJ; doses varied according to the minipump model 
used) in 6 μl saline per 24 hrs to each side of the brain.  Intracranial Fadrozole doses in 
this range have been reported to block the local conversion of E2 from T [30] and have 
been used successfully by other investigators [32, 151].  Prior to surgery, minipumps 
were incubated at 37o C for 48 hours in physiological saline to ensure full pumping 
activity at the time of brain implantation.  Males were given five to seven days to recover 
before weekly postoperative behavioral testing began.  Model 2002 minipumps (which 
dispense for 14 days) were replaced after 13 days but model 2004 minipumps (which 
dispense for 28 days) were not removed until the end of the study.  Fluid levels in all 
pumps were checked to determine that there had been no pump failures; none occurred.   
Experiment 2:  BSA-E2 and cholesterol administration to males.  Each male was 
anesthetized with isoflurane gas by placing them in a chamber with an atmosphere of 4% 
gas and an oxygen exchange rate of 500 cc per minute and transferring them to a 
nosecone dispensing 2-3% gas at 500 cc per minute oxygen exchange rate, castrated and 
implanted s.c. with a 10 mm Silastic capsule (1.981 mm id X 3.175 mm od) containing 
crystalline DHT (Sigma).  DHT capsules of this size have been reported to produce 
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circulating DHT levels in the physiological range [3, 82, 118] and were behaviorally 
effective in another study in which we used identical DHT capsules s.c. and found that 
mating occurred if male rats were given either E2 or BSA-E2 implants to the MPO, 
whereas DHT-treated males with vehicle MPO implants did not mate [61].  Thereafter, 
they were stereotaxically implanted bilaterally with 22 gauge stainless steel, ethylene 
oxide sterilized guide cannulae (Plastics One) aimed at the MEA (level skull coordinates: 
ap = -3.2 mm, ml = ± 3.5 mm, dv = -8.2 mm [146]).  Inner cannulae (28 gauge, Plastics 
One) extended 1 mm below the guide cannulae and were tamped in either:  (i) 1,3,5(10)-
estratrien-3, 17β-diol 17-hemisuccinate:BSA (Steraloids, Inc., Newport, Rhode Island, 
code E1077-000; BSA-E2 group) or (ii) a 1:40 (wt/wt) mixture of unconjugated, 
crystalline cholesterol (Sigma) plus unconjugated, crystalline BSA (cholesterol group), 
sterilized and inserted into the guide cannulae.  Males were given five to seven days to 
recover before the weekly postoperative behavioral testing began.  Freshly tamped, 
sterilized inner cannulae were inserted into the brain 48 hours before and 24 hours after 
every behavioral test.  In a group of pilot animals, daily microscopic inspection of 
cannula tips for crystalline material ensured that this replacement schedule would 
continuously expose the brain to the appropriate agent.  In addition, when cannulae from 
experimental animals were inspected, crystalline material was present at the cannulae tips 
at least 85% of the time.  There were 7 animals in the BSA-E2 group and 8 animals in the 
cholesterol group.   
Sexual behavior tests.  During preoperative sexual screening and postoperative 
mating tests, each male was paired with a sexually receptive female for 30 minutes in a 
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22 x 44 x 50 cm testing arena under dim red light.  Tests of this duration are sufficiently 
long for male rats to obtain multiple ejaculations with females, and a 30 minute test 
length is also used by other investigators [15].  Tests began 3 hours after lights off.  The 
following behaviors were recorded by observers blind to the experimental status of the 
animals:  mount frequency (MF) - the number of mounts without penile penetration; 
intromission frequency (IF) - the number of mounts with penile penetration; and 
ejaculation frequency (EF) - the number of ejaculations.  We also measured mount 
latency (ML) - time from the beginning of the test until the first mount or intromission or 
a default of 1800 sec if no mounts occurred; ejaculation latency (EL) - time from the first 
mount or intromission until the first ejaculation or a default of 1800 sec if no ejaculations 
occurred; and the post-ejaculatory interval (PEI) - time between the first ejaculation and 
the next mount or intromission or a default of 1800 sec if neither occurred.   
Histological verification.  When the testing period was concluded, males were 
euthanized with an overdose of sodium pentobarbital (100 mg/kg i.p.) and perfused 
transcardially for 5 minutes with physiological saline followed by a minimum of 300 ml 
of a fixative containing 2% paraformaldehyde and 0.1% picric acid in 0.1 M phosphate 
buffer (PB) solution (pH 7.4).  Skulls were partially opened and immersed overnight in 
perfusion fixative.  Brains were removed from skulls the next day and stored in 30% 
sucrose in 0.1 M PB for approximately 48 hours.  Frozen coronal brain sections (40 μm) 
through the diencephalon were collected into 0.1 M PB, mounted on gel-albumin coated 
slides and stained with Toluine blue to verify cannula placement.   
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 Statistics.  Between-group behavioral data were analyzed by repeated measures 
(group by trial) analysis of variance, followed by post hoc comparisons using the Tukey 
honestly significant differences test at a probability level of 0.05; and within-group 
comparisons of preoperative and postoperative changes in behavior were analyzed by 
paired t-tests [69].  Data from all males was used in the statistical analyses; default values 
(see sexual behavior tests) were used in situations where animals did not display a given 
behavior.  Two-tailed probabilities are reported in all cases. 
 
RESULTS 
Experiment 1 
 Male Sexual Behavior:  Relative to saline-infused controls, which displayed 
robust mating behavior postoperatively, animals infused with Fadrozole to the MEA 
demonstrated statistically significant reductions in intromission frequency (group main 
effect:  F1,18 = 9.08, p < 0.007, group x trial interaction:  F3,54 = 2.89, p < 0.043) and 
ejaculation frequency (group main effect:  F1,18 = 6.26, p < 0.021), whereas mount 
latency (group main effect:  F1,18 = 8.13, p < 0.01, group x trial interaction:  F3,54 = 4.29, p 
< 0.009), ejaculation latency (group main effect:  F1,18 = 5.55, p < 0.028) and the post-
ejaculatory interval (group main effect:  F1,18 = 12.97, p < 0.002) were significantly 
increased.  Mount frequency did not differ significantly between the two groups 
(FIGURE 9 and TABLE 1).  Follow-up post hoc statistical comparisons indicated that 
intromission frequency was significantly reduced (p < 0.05) in Fadrozole-infused males 
relative to saline-infused controls on the fourth postoperative week, whereas ejaculation 
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frequency was significantly depressed (p < 0.05) on the third postoperative week.  
Similarly, Fadrozole-infused animals had significantly longer (p < 0.05) mount latencies 
on the fourth postoperative week, significantly greater (p < 0.05) ejaculation latencies on 
the third postoperative week and significantly larger (p < 0.05) post-ejaculatory interval 
scores on the third and fourth postoperative weeks.  In saline controls, for each dependent 
variable, there were no significant differences between performance on the last week 
immediately preceding surgery (representing terminal preoperative performance) and the 
last postoperative week (representing terminal postoperative performance).  No 
significant differences were noted between groups on any behavioral measure during 
preoperative weeks.  In the Fadrozole group, however, comparisons between last 
preoperative week and the last postoperative test indicated there was a significant decline 
in mount frequency (t = 4.21, df = 8, p < 0.003) and intromission frequency (t = 2.81, df 
= 8, p < 0.02) and a significant increase in mount latency (t = 4.13, df = 8, p < 0.003) 
after surgery.   
 Cannula Placements:  Locations of cannula placements are indicated in FIGURE 
10.  Cannula tips were positioned in or near the medial amygdala in both groups of 
animals.   
 
Experiment 2 
 Male Sexual Behavior:  Vehicle-implanted controls demonstrated modest, but 
significantly lower, intromission frequency (group main effect:  F1,13 = 5.02, p < 0.041) 
and ejaculation frequency (group main effect:  F1,13 = 6.00, p < 0.028) than did animals 
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given BSA-E2 to the MEA, and their post-ejaculatory interval (group main effect:  F1,13 = 
7.72, p < 0.015) was significantly longer.  Follow-up post hoc comparisons revealed no 
other significant group differences (FIGURE 11 and TABLE 2).  Each group exhibited 
robust mating prior to surgery and did not differ significantly on any behavioral measure.  
Postoperatively, each group showed a significant decline in mating behavior.  In the 
group implanted with BSA-E2 to the MEA, comparisons of the performance on the last 
preoperative week and the last postoperative week indicated that mount frequency (t = 
2.89, df = 6, p < 0.028), intromission frequency (t = 4.41, df = 6, p < 0.018) and 
ejaculation frequency (t = 3.05, df = 6, p < 0.022) were significantly reduced 
postoperatively.  Moreover, in the vehicle-implanted group, comparisons between the 
preoperative last week and the last postoperative test revealed that mount frequency (t = 
3.01, df = 7, p < 0.02), intromission frequency (t = 5.23, df = 7, p < 0.0012) and 
ejaculation frequency (t = 2.99, df = 7, p < 0.02) were significantly lower 
postoperatively; and mount latency (t = 2.54, df = 7, p < 0.039), ejaculation latency (t = 3. 
51, df = 7, p < 0.0099) and the post-ejaculatory interval (t = 3.81, df = 7, p < 0.0067) 
were significantly increased.   
 Cannula Placements:  Locations of cannula placements are indicated in FIGURE 
12.  Cannula tips were positioned in or near the medial amygdala in both groups of 
animals.   
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DISCUSSION 
These studies had two goals:  (i) to demonstrate the necessity of E2 in the MEA 
for the expression of male sexual behavior and (ii) to begin to investigate the 
mechanism(s) by which E2 mediates the behavior.  The first study showed that inhibiting 
the aromatization of T to E2 in the MEA resulted in significant reduction of male sexual 
behavior, supporting the hypothesis that E2 acts in the MEA to promote male mating 
behavior. This extends previous reports that E2 implants to the MEA mediate sexual 
behavior [59].  The second study showed that BSA-E2 implants to the MEA did not 
support mating, counter to the hypothesis that E2 would act at the plasma membrane in 
the MEA to maintain mating behavior.   
Our findings from the first experiment support the idea that estrogenic metabolites 
of T act in the MEA to facilitate the expression of male rat mating behavior.  
Administration of E2 to the cortical amygdala of castrated male rats restored mounting 
behavior [126], and E2 administered to the MEA of castrated male hamsters increased 
mounting and other non-couplatory responses associated with mating behavior [167].  In 
another study with gonadally intact rats, systemic Fadrozole administration reduced 
mating, but mounting and intromission were maintained by E2 (but not vehicle) implants 
to the MEA of Fadrozole-treated males [59].  In the present study with gonadally intact 
rats, we showed that blocking the formation of E2 from T in the MEA via chronic 
infusion of Fadrozole reduced all indices of sexual behavior but did not entirely eliminate 
mating.  Together, these findings suggest that E2 acts within the male rat MEA to 
promote mating behavior.   
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Blocking the formation of E2 in the MPO also attenuates mating behavior [32].  
Specifically, gonadally intact males receiving chronic infusion of Fadrozole to the MPO 
displayed severe deficits in mounting, which ultimately resulted in significantly 
suppressed ejaculation.  Conversely, all components of copulatory behavior were 
maintained, albeit at somewhat low levels, in males given Fadrozole s.c. and MPO E2 
implants [33].  Thus, converging evidence suggests that E2 acts within the MPO, the 
MEA and probably other brain areas where populations of E2-responsive neurons mediate 
copulatory performance.  While it is likely that both T and/or its androgenic metabolites 
[151] are also required for full, robust behavior to occur, it is clear that E2 is necessary in 
these brain areas, presumably acting through ER [116, 151, 162], although questions 
remain regarding the mechanism(s) by which E2 exerts its behavioral effects.   
Traditionally, it had been believed that E2 facilitates mating by acting genomically 
after binding to its intracellular receptors, translocating to the nucleus and interacting 
with DNA to induce mRNA transcription and protein synthesis [64, 68, 93, 164].  
Presumably, these E2-dependent proteins perform functions that might be conducive to 
the expression of certain behaviors.  It is possible these induced proteins are enzymes that 
enable the neurons to manufacture specific neurotransmitters that are required for mating.  
For example, E2 induces changes in levels of cholecystokinin (CCK) in brain areas that 
mediate female rat sexual behavior [99, 113, 137].  Moreover, T modulation of CCK has 
been reported to occur in areas of the male rat brain that are important for the display of 
copulatory behavior, and it is possible that these changes result from the aromatization of 
T to E2 [135].  These studies raise the possibility that E2 acts as a “chemical switch” [137] 
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regulating differential levels of neurotransmitters in behaviorally-relevant neurons.  Such 
slow genomic actions have been referred to as “classical” actions of E2; however, 
recently there have been reports of more rapid effects of E2.  These fast responses to E2 
are believed to be cell-signaling effects coupled to G protein or other pathways that 
induce, for example, intracellular calcium signals [21], phosphorylation [13], or kinase 
signaling [124, 139]; and they are presumed to be mediated by ERs associated with the 
plasma membrane, the intracellular membranes [128, 176], or the cytosol whose actions 
are at sites other than the nucleus [1, 139, 179].   
To further complicate attempts to define the role of E2 in behavior, there are two 
known “classical” receptor types, ER-alpha and ER-beta, and both types are found not 
only in the nucleus [49, 68, 76, 132] but also in the cytosol [10, 11, 79, 100, 101, 179] 
and can be inserted into the plasma membranes [127].  Because of the well documented 
role that E2 plays in the MPO and the MEA in the expression of male mating, and 
because so little is known about the mechanism(s) of its action, we investigated the 
behavioral effects of blocking the synthesis of ER-alpha by chronically infusing antisense 
oligodeoxynucleotides (ODN) complementary to the start translation site of ER-alpha 
mRNA into the MPO and MEA.  Chronic infusion of ODN to the MPO attenuated 
mating, but ODN infusion to the MEA had no discernable effects on copulation, 
suggesting that E2 is acting differently in these two brain areas [116].  These findings 
suggest that ER-alpha is the behaviorally-relevant ER in the MPO but not the MEA.  This 
raises questions such as:  Which ER is behaviorally relevant in the MEA? and How does 
E2 exert its differential effects in the MPO and MEA?  It is possible that ER-beta is 
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behaviorally relevant in the MEA; however, studies in mice do not support this 
interpretation [162].  Another possibility is that a plasma membrane-associated ER of 
classical or novel form mediates the response to E2 in the MEA.  We used a membrane-
impenetrant form of E2 to test the latter possibility.   
Previous studies have successfully shown that conjugation of a steroid to BSA, a 
large protein that does not cross the plasma membrane, can demonstrate the rapid effects 
of membrane-associated receptors [47, 117, 125].  We therefore tested the efficacy of 
BSA-E2 administered to the MEA of castrated, DHT-treated male rats to maintain mating 
behavior.  Chronic delivery of BSA-E2 to the MEA did not maintain mating behavior and 
did not support our hypothesis, that E2 mediates sexual behavior by acting at the plasma 
membrane of E2-responsive MEA neurons.  Instead, BSA-E2-treated males exhibited 
significant declines in mating behavior compared to their preoperative levels.  Moreover, 
BSA-E2-treated males performed only slightly better than vehicle controls on a few 
indices of mating behavior.  Although we did not assay for the cleaved products in this 
experiment, it is unlikely there was cleavage of the bond between the BSA molecule and 
the hormone.  In a companion study in which BSA-E2 was administered to the MPO, 
immunocytochemistry using the H222 anti-ER antibody (which recognizes unoccupied 
ER) produced labeling, demonstrating that cleavage did not occur [61].  Furthermore, had 
cleavage occurred, E2 would have been free to enter MEA neurons and promote mating, 
as did the administration of E2 to the MEA in a previous study [59].  It is also unlikely 
that the concentration of E2 in the BSA-E2 was too dilute to support mating because the 
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dose used here was the same dose that stimulated mating when administered to the MPO 
[61].   
Blocking the synthesis of ER-alpha in the MEA did not attenuate sexual behavior, 
but the same treatment in the MPO significantly reduced mating [116].  Chronic 
administration of BSA-E2 to the MPO also maintained mating behavior [61], raising the 
possibility that the behaviorally-relevant ER (alpha) is associated with the plasma 
membrane of neurons in the MPO as suggested by Khan et al. [67].  This is not the case 
in the MEA, where stimulation of plasma membrane-associated receptors alone (if 
present in the MEA) via the use of BSA-E2 did not support mating.  Some investigators 
speculate that hormonal effects in the brain are transduced into behaviors when rapid 
membrane-mediated events act in concert with traditional genomic or classical models of 
hormone activity in the nucleus [154].  Whether or not this model is valid cannot be 
addressed by the data presented here.  Nevertheless, the Fadrozole study extends and 
validates the ideas that E2 acts in the male rat MEA to promote mating and that the local 
conversion of T to E2 is necessary for the expression of copulatory behavior.  We 
interpret the outcome of the BSA-E2 study as a guidepost indicating how E2 may act in 
the MEA.  We propose that E2 acts intracellularly within the MEA rather than at the 
plasma membrane, perhaps via a novel mechanism, to facilitate male rat copulatory 
behavior.   
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FIGURE 9 
Mating behavior (mean ± standard error of the mean, SEM) after Fadrozole or saline 
infusion of the MEA.  Males infused with saline to the MEA (gray squares) mated 
robustly, whereas those infused with Fadrozole to the MEA (circles) mated poorly, 
showing significantly fewer intromissions and ejaculations than saline controls.  Relative 
to saline controls, Fadrozole-infused animals showed significant increases in mount 
latency, ejaculation latency and the post ejaculatory interval.  Blackened circles indicate 
the weeks where post hoc statistical comparisons revealed that the Fadrozole group 
differed significantly from the saline group (p < 0.05, two-tailed).   
* Significant within-group difference between the last postoperative week and the last 
preoperative (PRE-) week (p < 0.02, two-tailed).   
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FIGURE 9 
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FIGURE 10 
Locations of cannula tips of animals infused with Fadrozole to the MEA (left) and those 
infused with saline (right).   Cannula tips were positioned in or near the medial amygdala.   
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FIGURE 10 
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FIGURE 11 
Mating behavior (mean ± SEM) after BSA-E2 or vehicle implants to the MEA.  Mating 
behavior was poor in both groups, although males implanted with BSA-E2 to the MEA 
(circles) showed slightly but significantly more intromissions and ejaculations compared 
to vehicle-implanted controls (gray squares), and the post ejaculatory interval was 
significantly shorter.  Post hoc statistical comparisons revealed there were no weeks 
where the BSA-E2 group differed significantly from the vehicle group. 
* Significant within-group difference between the last postoperative week and the last 
PRE- week (p < 0.04, two-tailed).   
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FIGURE 11 
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FIGURE 12 
Locations of implant tips of animals in the BSA-E2 conjugated group (left) and the BSA 
+ cholesterol group (right).  Implants were located in or near the medial amygdala.   
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FIGURE 12 
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TABLE 1 
Percent of Males That Copulated Within 1800 Seconds, by Behavior 
 
 
WEEK: 
 
 
 
 
BEHAVIOR: 
 
 
 
GROUP: Pre-
operative 
Week 
 
Week 1 
 
Week 2 
 
Week 3 
 
Week 4 
 
Fadrozole 
 
 
100% 
 
67% 
 
89% 
 
67% 
 
44% 
 
 
Mount 
Latency 
 
 
Saline 
 
 
100% 
 
100% 
 
91% 
 
100% 
 
100% 
 
Fadrozole 
 
 
67% 
 
67% 
 
44% 
 
22% 
 
33% 
 
 
Ejaculation 
Latency 
 
 
Saline 
 
 
100% 
 
91% 
 
82% 
 
91% 
 
91% 
 
Fadrozole 
 
 
67% 
 
67% 
 
44% 
 
22% 
 
33% 
 
 
Post-
ejaculatory 
interval 
 
Saline 
 
 
100% 
 
91% 
 
82% 
 
91% 
 
91% 
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TABLE 2 
Percent of Males That Copulated Within 1800 Seconds, by Behavior 
 
 
WEEK: 
 
 
 
 
BEHAVIOR: 
 
 
 
GROUP: Pre-
operative 
Week 
 
Week 1 
 
Week 2 
 
Week 3 
 
Week 4 
 
BSA-E2 
 
 
100% 
 
71% 
 
86% 
 
71% 
 
86% 
 
 
Mount 
Latency 
 
 
Cholesterol 
 
 
88% 
 
50% 
 
75% 
 
50% 
 
38% 
 
BSA-E2 
 
 
100% 
 
29% 
 
57% 
 
57% 
 
71% 
 
 
Ejaculation 
Latency 
 
 
Cholesterol 
 
 
75% 
 
13% 
 
38% 
 
25% 
 
13% 
 
BSA-E2 
 
 
100% 
 
29% 
 
57% 
 
57% 
 
71% 
 
 
Post-
ejaculatory 
interval 
 
Cholesterol 
 
 
75% 
 
13% 
 
44% 
 
13% 
 
13% 
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CHAPTER 4 
 
COLOCALIZATION OF STEROID HORMONE RECEPTORS AND 
PSEUDORABIES VIRUS FOLLOWING INJECTION INTO THE PROSTATE 
GLAND OF MALE RATS 
 
 
Gloria G. Huddleston, Song Kay, Jacquelyn C. Paisley, T. J. Bartness and Andrew N. 
Clancy, American Journal of Physiology, in preparation, 2006. 
 
 87
ABSTRACT 
Mating-induced Fos-immunoreactivity (ir) is colocalized with androgen 
Receptors (AR) or estrogen receptors (ER) or both in limbic and hypothalamic areas that 
have been shown to mediate the display of male rat mating behavior.  A steroid-
responsive neural network might govern copulatory behavior in males that is similar to 
the network described that governs the lordotic response in female rats.  It is probable 
that this hypothesized network synchronizes and coordinates sexual behavioral responses 
with physiological responses of the genitals and the internal reproductive organs 
associated with successful reproduction.  An attenuated form of the Bartha’s K strain of 
Pseudorabies Virus (PRV), a trans-synaptic retrograde tracer, was injected into the 
prostate gland (14 μl of 3 x 108 pfu).  After seven days, brains from infected animals were 
processed and double labeled for AR-ir + PRV-ir and ER-ir + PRV-ir.  The majority of 
PRV-ir neurons expressed either AR-ir or ER-ir the medial preoptic areas (MPO), the 
medial preoptic nucleus (MPN), the bed nucleus of the stria terminalis (BST), the 
paraventricular nucleus hypothalamus (PVH), and the zona incerta (ZI):  areas that have 
been shown to play a role in male mating.  Areas such as the periaqueductual gray (PAG) 
and the central nucleus of the amygdala (CEA) and the medial amygdala (MEA) that 
have also been shown to be instrumental in the display of male copulatory behavior were 
less reliably labeled.  Nevertheless, we described a steroid-responsive, neuronal circuit in 
the diencephalon that might initiate the motor aspect of mating and synchronize 
autonomic and behavioral sexual responses.   
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INTRODUCTION 
In female rodents a steroid-responsive brain network has been described that 
mediates lordosis, the female copulatory reflex [41, 119].  Because such a network exists 
in females, and because gonadal hormones must act on hypothalamic and limbic sites of 
the male rodent brain for sexual behavior to occur, it is reasonable to hypothesize that a 
similar brain neural network, composed of interconnected, steroid-sensitive neurons, 
mediates male mating behaviors.  Historically, lesion and stimulation studies have 
suggested that hypothalamic and limbic areas including, but not limited to, the medial 
preoptic area (MPO), the medial amygdala (MEA) and the bed nucleus of stria terminalis 
(BST) mediate male sexual behaviors [63, 97] and anatomical studies have shown that 
these areas are reciprocally interconnected [18, 38, 39, 136].  Moreover, neurons in each 
of these brain regions contain steroid hormone receptors, either androgen receptors (AR) 
alone, estrogen receptors (ER) alone, or both receptor types [51, 132].  Male sexual 
behavior is altered or attenuated when steroid hormone receptor antagonists to AR or ER 
are administered to the MPO or the MEA (and probably to the BST) [92, 94, 95, 152].  
Hormone manipulation studies using a variety of techniques, including inactivation of the 
aromatase enzyme that converts T to E2 [108], reinforce the idea that the display of male 
copulatory behavior is dependent on gonadal hormone action on the brain and suggest 
that the role of estrogen in male sexual behavior may be greater than previously 
recognized [12, 33, 59, 60, 116, 130].  Immunocytochemical (ICC) studies using Fos 
immunoreactivity (ir) as a marker of neuronal activity showed that mating-induced Fos-ir 
is colocalized with either ER-ir or AR-ir or both in these same brain areas [51].  Thus, it 
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is likely that the interconnected brain regions that make up the hypothesized steroid-
sensitive network synchronize and coordinate the sexual behavioral responses with the 
physiological responses of the peripheral genital apparatus and the internal reproductive 
organs associated with insemination.   
To test the hypothesis we injected an attenuated form of the pseudorabies virus 
(PRV), the Bartha’s K strain, a transneuronal, retrograde tract tracer, into a peripheral 
structure that is activated during mating, the prostate gland.  When this viral strain is 
introduced peripherally, it is taken up by autonomic motor neuron terminals [144].  Inside 
the infected neuron, the virus self-replicates and is transferred across synapses in a 
retrograde fashion to presynaptic axon terminals.  The process is repeated and viral 
infection spreads from neuron-to-neuron in a chain-like fashion [19, 20] such that, with 
anti-PRV ICC, an entire multisynaptic neural network can be visualized, one that 
presumably controls the functions of the peripheral structure.  We elected to infect the 
prostate gland with PRV because the expulsion of prostatic fluid is temporally 
synchronized with the ejaculatory behavioral pattern, which suggests that activity in a 
common, supraspinal circuit may trigger both the expulsion of prostatic fluid and the 
behavioral patterns associated with mating behavior.  We reasoned that PRV would infect 
the central neural network underlying mating behavior and we predicted that this network 
would be composed of steroid-sensitive neurons.  Brains were dually processed for the 
expression of PRV-ir and either ER-ir or AR-ir and we anticipated finding a high 
proportion of dual-labeled neurons in brain areas known to mediate male rat sexual 
behavior.   
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MATERIALS AND METHODS 
Animals 
 Male (371-605g) Sprague-Dawley rats, at least 70 days of age, were obtained 
from Charles River Laboratories.  Animals were housed singly in polycarbonate cages, 
22 x 44 x 18 cm, with free access to food and water in the university vivarium on a 14:10 
hour reversed light:dark cycle (lights off at 0930 hours).  All housing and experimental 
procedures were approved by the Institutional Animal Care facility and were in 
accordance with PHS guidelines.  Males were anesthetized to a surgical plane with 
sodium pentobarbital (40 mg/kg i.p., Veterinary Laboratories, Inc., Lenexa, Kansas) and 
the prostate gland was exposed via a small ventral incision directly over the bladder.  The 
prostate was supported by a sterile probe and the PRV was microinjected into the prostate 
glands of male rats using a Hamilton Syringe, as described in detail below.   
PRV Injection and dissection 
 Each animal (N = 20) received a total of 14 μl PRV (the virus titer was 3 x 108 
plaque forming units per ml), delivered as follows:  7 μl PRV was distributed into each of 
two prostatic lobes by microinjecting 1 μl followed by holding the syringe in place for 
one minute, then slightly moving the syringe to inject the next μl at a different sites in the 
lobe.  Animals were monitored daily for signs of infection or urinary discomfort.  After 
seven days, animals were given a lethal dose (100-150 mg/kg) of pentobarbital and 
perfused transcardially with physiological saline followed by a minimum of 300 ml of 
4% paraformaldehyde.  Skulls were partially opened and immersed in the perfusion 
fixative.  The next day, brains were removed from skulls and transferred to 30% sucrose 
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in 0.1 M sodium phosphate buffer (PB) (Ph 7.4) for three days.  Brains were immersed in 
0.1 M PB overnight, cut coronally into 40 μm sections with a freezing microtome, and 
then stored in 0.1 M PB.  Immunocytochemistry was used (see below) to visualize 
infected neurons.   
Immunocytochemistry 
Dual Labeling for ER-ir and PRV-ir 
 Sections were rinsed in fresh 0.1 M PB followed by a 24 h incubation in a 
blocking solution of 0.1 M PB + 0.4% Triton X (TX) + 5% normal goat serum (NGS) 
(Jackson Laboratories, Bar Harbor, ME) at room temperature with agitation.  Sections 
were then sequentially incubated with two different primary antibodies:  first, with the 
RB132 rabbit polyclonal anti-PRV antibody (gift of Dr. L Enquist, Princeton University, 
dilution = 1:10,000) in a solvent of 2% NGS and 0.1% sodium azide in 0.1 M PB + 0.4% 
TX for 24 h at room temperature with agitation, and second, with the 1D5 mouse 
monoclonal anti-ER antibody (Zymed Laboratories, South San Francisco, catalogue # 18-
7149 concentration = 1 μg/ml) in a mixture of 2% NGS in 0.1 M PB + 0.4% TX for 48 h 
at room temperature with agitation.  After three 5 min washes in 0.1 M PB, sections were 
incubated in a mixture of two secondary antibodies:  (i) biotinylated goat anti-rabbit 
secondary antibody (1:350 dilution, Vector Laboratories, Burlingame, CA catalogue # 
BA-1000, Lot No. A0708) and (ii) gold-conjugated goat anti-mouse secondary antibody 
(1:200 dilution, Jackson Laboratories, catalogue # 115-185-100, Lot No. 44811) in a 
solution of 0.1 M PB + 0.4% TX + 3% NGS for 2 h at room temperature with agitation.  
For the peroxidase reaction, sections were washed three times for 5 min in 0.1 M PB, 
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incubated in one-tenth-strength avidin-biotinylated peroxidase complex (Vector 
Laboratories, Vectastain Elite standard ABC peroxidase kit) in 0.1 M PB for 60 min at 
room temperature with agitation, washed in three times for 5 min in 0.1 M PB, and then 
incubated in a mixture of diaminobenzidine (DAB, Sigma, St. Louis, MO concentration = 
0.2 mg/ml) and H2O2 (Sigma, concentration = 0.1μl/ml) in 0.1 M PB for 5 min at room 
temperature.  For the silver-enhancement reaction, sections were washed three times for 5 
min in deionized water, incubated in silver-enhancement reagents (BBI Silver 
Enhancement kit, Ted Pella, Redding, CA prepared according to the manufacturer’s 
directions) for 20 min at 4°C and then washed three more times in deionized water for 5 
min each.  Finally, after three additional 5 min washes in 0.1 M PB, sections were 
mounted, dehydrated in alcohol, cleared with xylene, and cover-slipped with DPX 
mountant.  Positive control sections from previously verified PRV infected animals were 
included in each assay for assay reliability.   
Dual Labeling for AR-ir and PRV-ir 
 Sections adjacent to those used in the ER-ir + PRV-ir ICC assay were dually 
processed for AR-ir and PRV-ir as described above except that the incubation in the NGS 
blocking solution was at 4o C, the silver-enhancement reaction was conducted at room 
temperature, and different primary and secondary antibodies were used.  At the 
appropriate steps in the procedure, sections were sequentially incubated with two 
different primary antibodies:  first, with a porcine polyclonal anti-PRV antibody (gift of 
Dr. L Enquist, dilution = 1:30,000) in a solvent of 5% NGS in 0.1 M PB + 0.4% TX, for 
24 h at 4o C, and second, with the PG-21 rabbit polyclonal anti-AR antibody (Upstate, 
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Cat. No. 06-680, Lot No. 24732, concentration = 3 μg/ml) in the same solvent for 48 h at 
4o C.  After three 5 min washes in 0.1 M PB, sections were incubated in a mixture of two 
secondary antibodies:  (i) biotinylated goat anti-swine secondary antibody (1:200 
dilution, Vector BA-9020, Lot No. K0223) and (ii) gold-conjugated goat anti-rabbit 
secondary antibody (1:200 dilution, BBI LM.GAR5, Batch No. 2697) in a solution of 0.1 
M PB + 0.4% TX + 5% NGS for 2 h at room temperature with agitation.  Positive control 
sections from previously verified PRV infected animals were included in each assay for 
assay reliability.   
Immunocytochemical controls 
Additional sections from each rat were processed in both the ER-ir + PRV-ir and 
the AR-ir + PRV-ir ICC assays, as above, but without any primary antibodies (zero 
primary antibody controls):  this resulted in no labeling.  Other sections were used as 
controls to test for cross-reactions between primary and secondary antibodies.  The cross-
reaction control sections were processed as above except that they were incubated with 
only one of the primary antibodies and both secondary antibodies, specifically: (i) RB132 
and without 1D5, (ii) 1D5 and without RB132, (iii) the porcine anti-PRV antibody and 
without PG-21 and (iv) PG-21 and without the porcine anti-PRV antibody.  These 
procedures, as expected, produced single-labeling only, indicating (i) that each primary 
antibody reacted normally with the appropriate secondary antibody and did not cross-
react with the other secondary antibody, and (ii) that the secondary antibodies did not 
cross-react with each other.  No dual-labeled or inappropriately single-labeled neurons 
were found in any of these control tissue sets. 
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Imaging and Quantification 
For each brain section, digital serial photomicrographs were made at sufficiently 
high resolution to visualize individual labeled neurons (FIGURE 13).  These 
photomicrographs were then melded together via a computer imaging program 
(Photoshop version 6.0) to make one image.  The resulting photomicrograph was then 
magnified and section boundaries and major landmarks were traced onto it, as were the 
locations of cells staining positive for PRV-ir (with and without AR-ir or ER-ir).  These 
tracings, with plotted cell locations, were mapped onto matching standard rat brain atlas 
plates by superimposing the tracings over the atlas plates via computer imaging and 
transferring the positions of the labeled cells to the plates; cells were then counted from 
these atlas plates using the regional boundaries and nomenclature of Swanson [146].   
 
RESULTS 
 PRV successfully infected 11 of 20 rats, although there was considerable 
individual variation in the amount of infection per animal.  In the diencephalic area of the 
brain, PRV labeled cells were located in several hypothalamic nuclei, notably the anterior 
hypothalamus (AHA), the bed nucleus of the stria terminalis (BST), the suprachiasmatic 
nucleus (SCN), the paraventricular nucleus hypothalamus (PVH), the median preoptic 
area (MEPO), the medial preoptic area (MPO), the medial preoptic nucleus (MPN), the 
retrochiasmatic hypothalamus, the lateral hypothalamus (LH), the dorsal medial 
hypothalamus (DM), the ventromedial hypothalamus (VMH) and the posterior 
hypothalamus (PH).  Other areas exhibiting PRV infections were the premammallary 
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nucleus (PM), the arcuate nucleus (ARC), the ventral tegmental areas, the zona incerta 
(ZI), the periaqueductual gray (PAG) and the central nucleus of the amygdala (CEA) and 
the medial amygdala (MEA).   
 Because there was considerable individual variation in the extent of PRV-ir 
neuronal labeling among the eleven rats that developed infections, the four cases most 
heavily labeled by PRV-ir were mapped and quantified in entirety (TABLES 3 and 4).  
The remainder of the PRV-ir labeled cases (N = 7 rats) were not quantified because PRV-
ir neuronal labeling was sparse (fewer than 5 PRV-ir neurons in the MPO).   
Distribution of PRV-ir and ER-ir Labeling 
 Examples of ER-ir single-labeled neurons (FIGURE 14A), PRV-ir single-labeled 
neurons (FIGURE 14B) and PRV-ir + ER-ir dual-labeled neurons (FIGURE 14C) were 
found in all mapped cases.  Injection of PRV into the prostate gland produced selective 
labeling of the brain, which is illustrated in two cases, the first of which (FIGURE 15) is 
more heavily labeled than the second (FIGURE 16); in both figures, PRV-ir single-
labeled neurons (as shown in FIGURE 14B) are represented as open circles and PRV-ir + 
ER-ir dual-labeled neurons (as shown in FIGURE 14C) are represented as filled circles.  
PRV-ir labeling, with and without ER-ir, was consistently present in the MPO (including 
the MPN), the BST, PVH, ZI and in a continuum of cells in the perifornical area that 
extended through the LH to the PH.  Sparser and/or inconsistent PRV-ir labeling also was 
noted in the CEA, MEA, VMH and PAG.   
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Distribution of PRV-ir and AR-ir Labeling 
Examples of AR-ir single-labeled neurons (FIGURE 14D), PRV-ir single-labeled 
neurons (FIGURE 14E) and PRV-ir + AR-ir dual-labeled neurons (FIGURE 14F) were 
found in all mapped cases.  The distribution of PRV-ir labeling, with or without AR-ir, 
matched very closely the distribution described above for PRV-ir, with or without ER-ir, 
even though different anti-PRV primary antibodies were used and is depicted for two 
cases (FIGURE 17, the more densely labeled case and FIGURE 18).  PRV-ir single-
labeled neurons are shown as open circles and PRV-ir + AR-ir dual-labeled neurons are 
shown as filled circles.  To facilitate comparisons between the distribution of PRV-ir + 
AR-ir labeling and that of PRV-ir + ER-ir, FIGURES 15 and 17 are from one animal.  
FIGURES 16 and 18 are also from one animal (a different case from that plotted in 
FIGURES 15 and 17).  PRV-ir labeling, with and without AR-ir, was consistently present 
in the MPO (including the MPN), BST, PVH, ZI and in a continuum of perifornical cells 
in the LH to the PH, and less consistently present and/or more sparse in the CEA, MEA, 
VMH and PAG.   
Quantification of Dual Labeling 
 For each of the four mapped cases, TABLE 3 provides total counts of PRV-ir 
neurons and the percentages of those that also expressed ER-ir and TABLE 4 presents 
total counts of PRV-ir neurons and the percentages that were AR-ir.  In the MPO, MPN, 
BST, and PVH there was a high degree of both ER-ir and AR-ir labeling in PRV-ir 
neurons.   
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DISCUSSION 
 After injection into the prostate gland, PRV, which is taken-up by both 
parasympathetic and sympathetic motor neurons [7], produced labeling in areas of the rat 
brain that are instrumental in autonomic function and several of these areas have 
previously been shown to mediate male mating behavior, specifically the MPO, BST, ZI 
and PAG.  Moreover, in these areas and also in the PVH, the majority of cells staining 
positive for PRV-ir also expressed either ER-ir or AR-ir.  This result supports the 
hypothesis and is consistent with the idea that, in the brain, a network composed of 
interconnected steroid-responsive neurons promotes the display of male copulatory 
behavior.  The present findings reinforce earlier reports that mating-induced Fos-ir is 
colocalized with steroid receptors in neurons in these same brain areas [51].   
 The idea that mating behavior is controlled by a supraspinal neuronal network that 
integrates exogenous and endogenous cues is not new.  Such a circuit has been described 
for the lordotic posture in females [41, 119] however; the hypothetical supraspinal circuit 
in males has received less attention.  Convergent evidence from past research implicating 
brain areas that are important for the expression of male mating correlates with brain 
areas labeled by PRV-ir in this study, however, the pattern of information flow through 
this pathway or circuit and its steroid-responsiveness have yet to be fully described.  In 
this study, by infecting the prostate gland with PRV, we labeled elements, principally in a 
forebrain diencephalic circuit, that presumably mediate both autonomic and motor 
aspects of male mating.  Many of these PRV-ir neurons in the MPO, MPN, BST, ZI and 
PAG were found to be steroid responsive.  The distribution of labeling from our study is 
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in agreement with previous studies that introduced PRV into the prostate gland [114, 178] 
or prostate gland and urinary bladder [107] but no other study has, to our knowledge, 
shown the steroid-sensitivity of the PRV-ir labeled neurons.  This steroid responsiveness 
is an important feature of a supraspinal network that controls mating behavior.  Thus, if 
such a circuit exists, it will show:  (i) activity with mating, (ii) steroid sensitivity and (iii) 
connections with peripheral structures involved in mating.  Our results are consistent with 
the identification of such a circuit.   
 It is universally accepted that the MPO plays a central role in the expression of 
vertebrate male sexual behavior.  Lesions of the MPO eliminate male mating behavior 
[28, 56, 78] and stimulation of the MPO facilitates it [43, 44, 87, 153].  Not surprisingly, 
destruction of the MPN, a major subnucleus of the MPO also disrupts male mating [145].  
Lesions of the BST and/or the stria terminals (st; a fiber tract that connects the amygdala 
with the MPO) interrupts male mating but to a lesser extent than do lesions of the MPO.  
Specifically, BST and st lesions generally affect the cadence of mating, resulting in 
increased frequencies of behaviors preceding ejaculation and longer latencies until 
ejaculation occurs [45, 48, 150, 177].  Lesions that include the ZI virtually eliminate male 
mating behavior [85].  Studies that combined PAG lesions with MPO stimulation suggest 
that the descending pathway for male sexual behavior passes through the PAG from the 
MPO [89].   
 PRV-ir labeling also occurred in some brain areas that traditionally have not been 
associated with male mating.  For example, heavy PRV-ir occurred in the all cellular 
layers of the PVH and in a continuum of perifornical cells through the LH and PH.  This 
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is not unexpected because these brain areas are involved in control of numerous 
autonomic targets and many sexual responses have an autonomic component, among 
them, vasodilatation, vasoconstriction, emission, secretions from seminal vesicles, 
contraction of the prostate, vas deferens and other reproductive organs.  Interestingly, 
mating-induced Fos-ir has been reported in the PVH of male rats [8, 58, 70, 166].  
Moreover, lesions of the parvocellular PVH are associated with a “decrease in seminal 
emission at the time of ejaculation” [2] and there are suggestions that the PVH might be 
involved in the supraspinal control of ejaculation [166].  Moreover, some PVH neurons 
project to the spinal nucleus of bulbocavernosus (SNB) [156, 157], a spinal cord area that 
regulates penile reflexes [16] and several studies have suggested that the descending 
oxytocinirgic neurons of the PVH play a role in male sexual behavior [4, 23, 62].   
 The central tegmental field (also known as the posterior subparafascicular nucleus 
of the thalamus) (CTF/SPFp) and the MEA showed little or no PRV-ir.  This was 
unexpected because both areas are known have direct reciprocal connections to the MPO, 
and both express mating-induced Fos-ir colocalized with steroid hormone receptors [51-
53].  We expected to see dense PRV-ir in steroid-sensitive neurons of the MEA because 
previous studies from our laboratory demonstrated that estradiol (E2) acts in the MEA to 
promote sexual behavior, which is attenuated in the absence of E2 in the MEA.  
Specifically, blocking responses to E2 by inhibiting the conversion of E2 from T [60], or 
knocking-down the expression of ER-alpha receptors in the MEA [116] causes severe 
deficits in mating.  Conversely, E2 implants to the MEA promote mating [59].  Moreover, 
it has been well documented that both pheromonal and chemosensory cues vital for 
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mating are processed in the amygdala [110].  These sensory related functions, which are 
hormone dependent, suggest that the amygdala interfaces with brain areas that mediate 
the motor aspects of mating and might modulate activity in the MPO.  It is possible that, 
given more time, cells in the amygdala would have become PRV infected, but in this 
study they did not, perhaps because they are one or more synapses removed from regions 
(such as the MPO) that mediate motor aspects of mating.   
 A series of recent studies has defined a spinal ejaculation generating center in the 
lumbar spinal cord [149, 35], highlighting a set of neurons that are specifically activated 
with ejaculation.  PRV studies have shown that these cells receive input from the prostate 
and bulbospongiosus muscle, supporting the idea that the spinal generating center 
coordinates emission and ejaculation [172, 173].  These lumbar neurons ascend the spinal 
cord and terminate in the CTF/SPFp, which has reciprocal connections to the MPO [52, 
53].  The MPO is heavily reciprocally connected to the BST and MEA; thus, these 
ascending spinal neurons probably transmit ejaculatory information to the brain.  Because 
CTF/SPFp neurons appear to be activated as a consequence of ejaculation, it is possible 
that such genital/somatosensory feedback information to motor brain regions controlling 
mounting behavior (such as the MPO) is indirect.  In the present study, there might not 
have been sufficient time for cells in the CTF/SPFp to have become PRV infected if they 
are also one or more synapses removed from the MPO.   
 Mating behavior does not always end in ejaculation.  Not all mounting behavior 
leads to intromission and not all mounts with intromission lead to ejaculation.  Because 
gonadal steroid hormones must act in the brain for mounting to be initiated, presumably a 
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steroid-responsive brain network integrates exogenous sensory cues with the motor 
output needed to initiate mating behavior.  This network, in all probability, synchronizes 
not only the autonomic motor neurons but also the skeletal motor neurons necessary for 
mating.  Perhaps primary somatosensory feedback is constantly being received and 
integrated in the brain which, in turn, signals peripheral structures, coordinating mating 
postures and insemination.  Such central-peripheral-central circuits and their mechanisms 
of hormonal regulation are not yet fully understood but Fos-ir labeling patterns and 
hormone manipulation studies have predicted a circuit for the initiation of mating made 
up of steroid-responsive neurons.  The PRV-ir labeling patterns observed in this study 
provides evidence supporting this idea.  Collectively, the results of this study suggest that 
we have begun to identify a steroid-responsive, supraspinal neuronal circuit that 
integrates and initiates the motor aspect of mating and that synchronizes autonomic 
responses with behavioral components.   
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FIGURE 13 
Method for preparation of maps describing the distribution of PRV-ir in the male rat 
brain.  High resolution photomicrographs of sections were melded together via computer 
and the positions of labeled cells and major landmarks were drawn.  These tracings were 
then superimposed onto standard rat atlas plates and the positions of PRV-ir cells were 
transferred to the atlas plates. 
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FIGURE 13 
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FIGURE 14 
Examples of neuronal labeling:  A. ER-ir single-labeled neurons (blue arrows), B. PRV-ir 
single-labeled neuron (red arrow), C. PRV-ir + ER-ir dual-labeled neuron (green arrow), 
D. AR-ir single-labeled neuron, E. PRV-ir single-labeled neuron and F. PRV-ir + AER-ir 
dual-labeled neuron.   
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FIGURE 14 
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FIGURE 15 
Distribution of PRV-ir + ER-ir in a heavily-labeled case.  Open circles represent PRV-ir 
single-labeled neurons and closed circles represent PRV-ir + ER-ir dual-labeled neurons.   
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FIGURE 15 
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FIGURE 15, continued 
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FIGURE 15, continued 
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FIGURE 16 
Distribution of PRV-ir + ER-ir in a lightly-labeled case.  Open circles represent PRV-ir 
single-labeled neurons and closed circles represent PRV-ir + ER-ir dual-labeled neurons.   
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FIGURE 16 
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FIGURE 16, continued 
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FIGURE 16, continued 
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FIGURE 17 
Distribution of PRV-ir + AR-ir in a heavily-labeled case.  Open circles represent PRV-ir 
single-labeled neurons and closed circles represent PRV-ir + AR-ir dual-labeled neurons.   
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FIGURE 17 
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FIGURE 17, continued 
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FIGURE 18 
Distribution of PRV-ir + AR-ir in a lightly-labeled case.  Open circles represent PRV-ir 
single-labeled neurons and closed circles represent PRV-ir + AR-ir dual-labeled neurons.   
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FIGURE 18 
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FIGURE 18, continued 
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TABLE 3 
PRV-ir and ER-ir 
PRV-ir + ER-ir 
 
9 
 
24 
 
11 
 
26 
SUMMARY 
(Mean ± SEM) 
 
CASE #: 
 Total 
cell # 
% 
ER-ir 
Total 
cell # 
% 
ER-ir 
Total 
cell # 
% 
ER-ir 
Total 
cell # 
% 
ER-ir 
Total 
cell # 
% ER-ir 
 
BRAIN AREA: 
 
          
MPO @ -0.46 N/A  31 74% 15 87% 7 86% 17.7 ± 
7.1 
82.3 ± 
4.2% 
MPO @ -0.51 29 79% 60 77% 11 64% N/A  33.3 ± 
14.3 
73.3 ± 
4.7% 
MPN @ -0.46 N/A  8 75% 4 100% 2 50% 4.7 ±  
1.8 
75.0 ± 
14.4% 
MPN @ -0.51 13 69% 12 92% 1 100% N/A  8.7 ± 3.8 87.0 ± 
9.3% 
BST @ -0.46 N/A  12 67% 6 50% 3 67% 7.0 ±  
2.6 
61.3 ± 
5.7% 
BST @ -0.51 55 69% 20 55% 4 100% N/A  26.3 ± 
15.1 
74.7 ± 
13.3% 
BST @ -1.08 3 33% 0 0% N/A  7 14% 3.3 ± 2.0 15.7 ± 
9.6% 
PVH @ -1.08 10 40% 4 100% N/A  2 0% 5.3 ± 2.4 46.7 ± 
29.1% 
PVH @ -1.78 2 50% 10 60% 8 88% 30 50% 12.5 ± 
6.1 
62.0 ± 
9.0% 
CEA @ -1.78 3 67% 0 0% 0 0% 0 0% 0.75 ± 
0.75 
16.8 ± 
16.8% 
CEA @ -2.45 0 0% 0 0% N/A  0 0% 0.0 ± 0.0 0.0 ± 
0.0% 
MEA @ -2.45 1 0% 0 0% N/A  0 0% 0.3 ± 0.3 0.0 ± 
0.0% 
ZI @ -1.78 1 0% 0 0% 0 0% 0 0% 0.3 ± 0.3 0.0 ± 
0.0% 
ZI @ -2.45 17 82% 12 17% N/A  6 50% 11.7 ± 
3.2 
49.7 ± 
18.8% 
VMH @ -2.45 6 100% 3 0% N/A  4 75% 4.3 ± 0.9 58.3 ± 
30.0% 
PAG @ -4.45 0 0% 0 0% 0 0% 6 100% 1.5 ± 1.5 25.0 ± 
25.0% 
PAG @ -4.60 
 
N/A  N/A  N/A  N/A  N/A N/A 
PAG @ -5.65 
 
10 70% N/A  N/A  N/A  N/A N/A 
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TABLE 4 
PRV-ir and AR-ir 
PRV-ir + AR-ir 
 
9 
 
24 
 
11 
 
26 
SUMMARY 
(Mean ± SEM) 
 
CASE #: 
 Total 
cell # 
% 
AR-ir 
Total 
cell # 
% 
AR-
ir 
Total 
cell # 
% 
AR-
ir 
Total 
cell # 
% 
AR-ir 
Total 
cell # 
% AR-
ir 
BRAIN AREA: 
 
          
MPO @ -0.46 19 58% N/A  14 36% 5 40% 12.7 ± 
4.1 
44.7 ± 
6.8 % 
MPO @ -0.51 22 36% 25 52% 5 40% N/A  17.3 ± 
6.2 
42.7 ± 
4.8% 
MPN @ -0.46 11 73% N/A  9 33% 4 25% 8.0 ± 
2.1 
43.7 ± 
14.8% 
MPN @ -0.51 7 71% 5 20% 0 0% N/A  4.0 ± 
2.1 
30.3 ± 
21.1% 
BST @ -0.46 29 48% N/A  13 46% 2 100% 14.7 ± 
7.8 
64.7 ± 
17.7% 
BST @ -0.51 46 65% 19 84% 13 85% N/A  26.0 ± 
10.1 
78.0 ± 
6.5% 
BST @ -1.08 N/A  0 0% N/A  0 0% 0.0 ± 
0.0 
0.0 ± 
0.0% 
PVH @ -1.08 N/A  3 67% N/A  6 100% 4.5 ± 
1.5 
83.5 ± 
16.5% 
PVH @ -1.78 38 37% 18 33% N/A  36 56% 30.7 ± 
6.4 
42.0 ± 
7.1% 
CEA @ -1.78 18 44% 2 50% N/A  0 0% 6.7 ± 
5.7 
31.3 ± 
15.8% 
CEA @ -2.45 0 0% N/A  N/A  0 0% 0.0 ± 
0.0 
0.0 ± 
0.0% 
MEA @ -2.45 8 63% N/A  N/A  0 0% 4.0 ± 
4.0 
31.5 ± 
31.5% 
ZI @ -1.78 1 100% 2 50% N/A  0 0% 1.0 ± 
0.6 
50.0 ± 
28.9% 
ZI @ -2.45 27 74% N/A  N/A  4 50% 15.5 ± 
11.5 
62.0 ± 
12.0% 
VMH @ -2.45 4 75% N/A  N/A  1 100% 2.5 ± 
1.5 
87.5 ± 
12.5% 
PAG @ -4.45 17 82% 0 0% N/A  N/A  8.5 ± 
8.5 
41.0 ± 
41.0% 
PAG @ -4.60 N/A  3 67% N/A  6 100% 4.5 ± 
1.5 
83.5 ± 
16.5% 
PAG @ -5.65 13 69% 3 33% 0 0% 4 25% 5.0 ± 
2.8 
31.8 ± 
14.3% 
 122
CHAPTER 5 
 
GENERAL DISCUSSION 
 The findings presented here suggest that E2 plays an important role in the 
expression of male rat sexual behavior.  These studies extend previous reports that: (1) 
local aromatization of T to E2 in the brain is necessary for mating behavior to occur [44, 
83, 108, 140, 141, 158], (2) mating-induced Fos-ir is colocalized with ER and AR in 
areas previously shown to exhibit steroid sensitivity [8, 36, 51, 70] and (3) it is likely that 
a steroid-responsive, supraspinal network coordinates male copulation.  Furthermore, our 
studies partially support earlier reports that implicate ER-α as the behaviorally relevant 
form of ER [112, 129].  We found that knockdown of ER-α in the MPO attenuates 
mating behavior whereas, disabling ER-α in the MEA has no effect.  This finding 
suggests differential mechanisms of ER action in the brain.  Moreover, to our knowledge, 
we report for the first time that stimulation of a form of mER is sufficient to elicit mating 
behavior, at least in the MPO but interestingly, not in the MEA, and to our knowledge, 
this is also the first report that the E2 remains conjugated to BSA in vivo.  Collectively, 
there are four main conclusions from these studies: (1) E2 acts in the brain to mediate 
expression of male copulatory behavior and plays a larger role than was previously 
appreciated, (2) the mechanisms by which E2 acts to promote mating varies in different 
brain areas, (3) depending on the brain area, a cell-surface stimulation of ER is sufficient 
for mating behavior to occur, and (4) supportive evidence was obtained for the existence 
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of  a steroid -responsive neural network that governs male sexual behavior, one that is  
similar to that described in females that mediates lordosis [41, 119].   
 In chapter 1 we hypothesized that the knockdown of ER-α in either the MPO or 
the MEA would suppress mating.  This hypothesis was partially supported: ER-α appears 
to mediate responses to E2 in the MPO, but ER-α is not necessary in the MEA for sexual 
behavior to occur.  In 1996, a novel form of ER was discovered; ER-β [76].  Because ER 
are reported to dimerize upon ligand binding [147], there is the possibility of either ER-α 
or ER-β homodimers or heterodimers.  There are few if any studies of the function of 
hetero- vs. homodimers.  Nevertheless, one may speculate that in the MPO there must be 
either homodimerization of ER-α, or heterodimerization (or both) for mating to occur, 
providing the mechanism by which behavior is expressed is via dimerization and 
selective transcription.  If the behavioral mechanism of ER is via a membrane receptor, 
then dimerization of receptors might be crucial in some brain areas, but not others.  Thus, 
we need to begin to ask new and different questions concerning the role of hormones and 
receptors in the display of mating behaviors. 
 Historically, E2 has been described as a transcription factor that, upon binding its 
cytoplasmic receptor, translocates to the nucleus and acts as a transcription factor [64, 68, 
93, 164].  Although it has been known for several years that E2 exerts rapid physiological 
effects (within seconds) on MPO [65] and MEA [106] neurons in vitro, only recently 
have reports of rapid effects of E2 become mainstream.  Initially, these rapid effects of E2 
(assumed to be non-genomic effects), were described as causing virtually instantaneous 
cell-signaling cascades.  We now know that the rapid, cell-signaling effects of E2 and 
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genomic actions of E2 are not necessarily mutually exclusive.  There is evidence to show 
that the rapid/cell signaling effects of E2 might, in fact, culminate in gene transcription 
[98, 160].  In studies aimed at finding and characterizing mERs there are some reports 
suggesting that mER is either ER-α or an isoform of ER-α [88, 101, 159].  Whatever the 
form of mER, we were interested in the possibility that mER might mediate sexual 
behavioral responses.  To that end, in Chapters 2 and 3 we used BSA-E2 to stimulate the 
mERs that might be associated with neurons of the MPO and MEA.  BSA is a large 
protein that will not permeate the plasma membrane and as shown in chapter 2, there is 
no cleavage of the bond conjugating BSA to E2 in vivo.  Because the knockdown of ER-α 
in the MEA did not interfere with mating behavior, we hypothesized that the recently 
described, novel mER, GRP30 [128, 148] or some similar receptor, might mediate the 
copulatory behavior in the MEA.  Conversely, even though there are reports that mERs 
might be ER- α, we hypothesized that stimulation of mER in the MPO would not be 
sufficient to elicit mating behavior.  Neither hypothesis was supported.  Instead 
stimulation of mER (via BSA-E2) in the MPO supported male mating behavior at 
significantly higher levels than controls on all measured indices (Figure 6).  However, 
membrane-stimulation by BSA-E2 of the MEA was not sufficient to maintain mating 
behavior.  Our conclusions from these two studies are: (1) that E2 works through different 
mechanisms in the MEA and MPO, (2) that a cell surface action of E2 in the MPO is 
sufficient for mating behavior to occur, but (3) an intracellular, non-ER-α mechanisms is 
indicated in the MEA.  In addition, in Chapter 3, we performed the converse of the 
experiment presented in the Appendix.  By chronically administering Fadrozole 
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bilaterally to the MEA of intact male rats, we showed that mating behavior is attenuated 
(Figure 9), supporting and extending the evidence that E2 acts in the MEA to promote 
male sexual behavior (see Appendix).   
 Because gonadal steroid hormones act on brain hypothalamic and limbic sites to 
promote male mating behavior, and because mating-induced Fos-ir is colocalized with 
ER-ir and AR-ir in these sites [51], it is reasonable to hypothesize that these brain areas 
act together, under the influence of hormones, to mediate the display of copulation.  
The lordosis response in females and the ejaculatory component of male sexual behavior 
are reflexes that are under the control of the spinal cord.  Supraspinal modulation and 
control of the lordotic reflex has been described [41, 119].  Presumably there is a similar 
network in males that modulates the ejaculatory reflex.  If such a neural network exists, it 
must, by definition, have the following characteristics; (1) steroid responsiveness, (2) 
connectivity with peripheral structures that are involved in sexual behavior, (3) terminals 
in brain areas reported to be involved in sexual behavior (4) an ability to synchronize and 
coordinate the physiological and behavioral responses associated with copulation.   
 We reasoned that one could describe such a circuit by microinjecting PRV into 
the prostate gland, a gland whose only known function is fluid secretion and expulsion 
during mating.  PRV is a transynaptic retrograde tract tracer taken up by autonomic 
motor neuron terminals [144, 7].  Inside the infected neuron, self-replication occurs and 
the virus crosses synapses in a retrograde, chain-like fashion [19, 20].  Furthermore, by 
using dual labeling ICC with an anti-PRV antibody and either an anti-AR antibody or an 
anti-ER antibody, we hypothesized that we could visualize an entire multisynaptic, 
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steroid-responsive neural network that coordinates the expulsion of prostatic fluid and 
which might mediate with the behavioral patterns associated with mating.   
 PRV-ir + AR-ir and PRV-ir + ER-ir labeled cells showed a common distribution.  
This extends and supports the idea that both androgens and estrogens mediate mating.  
Thus, neither DHT nor E2 alone is as effective in maintaining or reinstating mating 
behavior as is either T alone or a combination DHT and E2 [63, 97].  Dual labeling was 
most consistently present in the MPO (including at least one of its subdivisions), the 
MPN, the BST, PVH, and ZI and in a continuum of cells surrounding the fornix that 
extended through the LH to the PH (Figures 15-18 and Tables 3-4).  With the possible 
exception of the LH and PH, each of these areas has been shown to be important in the 
display of male copulatory behavior [63, 97].  Unexpectedly, labeling in the CTF/SPFp 
and the MEA was light and inconsistent if present at all.  The CTF/SPFp and MEA 
contains steroid sensitive neurons [51, 52,] and both are part of an ascending neuronal 
pathway that is believed to transmit ejaculatory information from the spinal cord to the 
brain [35].  Both areas are reciprocally connected to the MPO, thus we cannot explain 
their lack of PRV-ir labeling.  Future studies will be necessary to determine both 
additional elements in the circuit described here and to test that it mediates male mating 
behavior as proposed.  Nevertheless, this study supports the idea of a central-peripheral-
central hormonally regulated circuit.  In conclusion, we believe that we have begun to 
identify a circuit that integrates and initiates the motor aspect of mating and that 
synchronizes autonomic responses with behavioral responses associated with mating.   
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 The overall conclusions from these studies are that:  (1) E2 acts in the brain to 
mediate expression of male copulatory behavior and plays a larger role than has been 
previously appreciated, (2) the mechanisms by which E2 acts to promote mating varies in 
different brain areas, (3) depending on the brain area, a cell-surface stimulation of ER is 
sufficient for mating behavior to occur, and (4) supportive evidence was obtained for the 
existence of a steroid-responsive neural network that governs male sexual behavior, one 
that is similar to that described in females that mediates lordosis [41, 119].   
 The significance of these studies is that they begin to elucidate how E2 acts in the 
brain to mediate behavioral responses.  This extends considerably our understanding of 
how hormones affect mating because previous research revealed WHERE, but not HOW, 
hormones act on the brain.  Understanding HOW hormones act is important because of 
the many roles that steroids play in the regulation of health and in the environment.   
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ABSTRACT 
HUDDLESTON, G.G., R.P. MICHAEL, D. ZUMPE AND A. N. CLANCY, Estradiol in 
the male rat amygdala facilitates mounting but not ejaculation.  PHYSIOL BEHAV 79 
239-246, 2003.  Mating activates estrogen sensitive neurons in several regions of male rat 
brain, including the medial amygdala (MEA).  Infusion of the aromatase inhibitor, 
Fadrozole, into the MEA reduced mating, presumably by inhibiting conversion of 
testosterone (T) to estradiol (E2).  We investigated whether administering E2 locally into 
the amygdala (AMG) would maintain sexual behavior in male rats given systemic 
Fadrozole to eliminate E2 elsewhere in the brain.  Gonadally intact male rats were divided 
into two matched groups, based on ejaculatory performance in weekly tests with 
receptive females.  All males received 0.29 mg/kg/day Fadrozole s.c. and bilateral 
implants to AMG.  E2-in-AMG males (N = 6 experimentals) received implants tipped 
with a cured mixture of E2 in Silastic Medical Adhesive, whereas Vehicle-in-AMG males 
(N = 6 controls) received implants tipped with cured adhesive alone (without E2).  In E2-
in-AMG males, postoperative mount and intromission frequency did not differ 
significantly from pretreatment baseline levels, but ejaculation frequency declined 
significantly (p<0.01).  Conversely, in Vehicle-in-AMG males, postoperative mounts and 
intromissions (p<0.01) and ejaculations (p<0.01) declined significantly.  Postoperative 
mount and intromission frequency of Vehicle-in-AMG males was significantly lower 
than that of E2-in-AMG males (p<0.01), but ejaculation frequency did not differ 
significantly between groups.  This suggests that E2-sensitive AMG neurons are 
important for sexual arousal but not ejaculatory performance. 
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INTRODUCTION 
The display of copulatory behavior by male mammals is dependent on testicular 
hormones acting on the brain as well as on peripheral structures.  Lesions, both electrical 
and chemical, have defined a number of brain sites that are believed to be important for 
sexual behavior.  Because neurons in many of these same sites contain androgen 
receptors (AR), estrogen receptors (ER) or AR colocalized with ER [1,2] several studies 
have investigated the effects of hormone deprivation, administration, and receptor 
blockade on behavior.  Testosterone (T) and its metabolites, dihydrotestosterone (DHT) 
and estradiol (E2), have been shown to affect the brain through receptor mechanisms 
without which, mating does not occur [3].  It is generally agreed that both T and E2 are 
necessary for full expression of male copulatory behavior, although neither the 
anatomical framework nor the hormonal requirement(s) for male sexual behavior is fully 
understood [97].   
Immunocytochemical (ICC) studies have shown that Fos, the protein product of 
the early immediate gene c-fos, is an accepted correlational marker for neuronal 
activation [105].  The same areas identified by lesion and stimulation methods as being 
important for sexual behavior show increased levels of Fos-immunoreactivity (ir) 
associated with mating [8].  In male hamster [70] and male rat [36, 51], the medial 
preoptic area (MPO), bed nucleus of the stria terminalis (BST), medial amygdala (MEA) 
and central tegmental field all contain neurons in which mating-induced Fos-ir is 
colocalized with either AR-ir or ER-ir alone, or with both AR-ir and ER-ir.   
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In a study measuring male rat mating and the neural formation of E2 from T, 0.25 
mg/kg/day s.c. of the aromatase inhibitor Fadrozole (CGS-15949A, CIBA-Geigy 
Corporation, Summit, NJ) significantly lowered copulatory behavior and inhibited by 
95% the manufacture of 3H-E2 from 3H-T in several areas of the brain [12].  A follow-up 
study, using an ICC assay based on the observation that E2 suppresses H222 ER-ir 
labeling in the brain [6, 29], confirmed that 0.25 mg/kg/day s.c. Fadrozole blocked 
synthesis of E2 from T [30].  Consequently, castrated male rats given Fadrozole and T, 
but not those maintained on T alone, exhibited abundant H222 ER-ir labeling throughout 
the brain [30].   
The MPO, one of the areas that colocalizes AR-ir and ER-ir, has been regarded as 
an integration site, essential for the display of male sexual behavior [97].  Gonadally 
intact male rats with bilateral E2 implants to the MPO plus 0.25 mg/kg/day s.c. Fadrozole 
expressed all components of sexual behavior at significantly higher levels than did 
controls, whose mating was significantly impaired, although the behavior of the E2–
implanted males was not robust [33].  Furthermore, H222 ER-ir labeling confirmed that 
E2 had been confined exclusively to the MPO.  Virtually no H222 ER-ir labeling 
occurred in the MPO of experimental males, although it was abundant in the MPO of 
controls and elsewhere in the brains of both groups [33].   
AR-ir and ER-ir are also colocalized in the MEA [51], an area that is reciprocally 
connected to the MPO in the rat [18] and in the hamster [39].  Estradiol implants in the 
corticomedial amygdala of castrated male rats restored mounting behavior, however, 
intromissions and ejaculations were not measured [126].  Similarly, in hamsters, E2 
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implanted into the posterior MEA of castrate males increased mounts and non-copulatory 
sexual behaviors [167].  We hypothesized that confining E2 to the MEA of male rats with 
a natural testosterone source would maintain all components of male sexual behavior at 
robust levels.  Therefore, gonadally intact male rats were treated with 0.29 mg/kg/day s.c. 
Fadrozole (a higher dose than used in previous studies) and divided into two groups:  
experimentals (E2-in-AMG) received bilateral implants of E2 directed at the MEA, and 
controls (Vehicle-in-AMG) received bilateral implants of vehicle directed at the MEA.  
H222 ER-ir labeling assessed the spread of E2 in the brain. 
 
EXPERIMENTAL PROCEDURES 
Animals.  Male (465-644 g) and female (276-300 g) Sprague-Dawley rats, at least 90 
days of age, were obtained from Charles River Laboratories or were bred in the 
laboratory.  Males and females were housed separately in plastic cages with free access to 
food and water in a climate-controlled rat colony under a 14:10 hour reverse light:dark 
cycle (lights off at 1000 hours).  All maintenance and surgical procedures were in 
accordance with institutional regulations and with the NIH Guide for the Care and Use of 
Laboratory Animals (NIH Publ. No. 85-23, revised 1985).   
Ten female rats were injected i.p. with 62.4 mg/kg sodium pentobarbital and then 
ovariectomized through a single midline abdominal incision.  At the same time, each 
female was also implanted s.c. with a 10 mm Silastic capsule filled with crystalline E2.  
Penicillin (0.1ml i.m. benzathine penicillin G + procaine penicillin G) and Banamine (0.3 
ml i.m.) was given post-operatively to relieve surgical discomfort and to reduce the 
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likelihood of infection.  Females were allowed a minimum of seven days recovery time 
before the start of behavioral testing.  Stimulus (E2-maintained) females received 1.0 mg 
progesterone s.c. (1mg progesterone/0.2 ml sesame oil) 4-6 hours before being tested 
with males.   
Male rats were screened for sexual behavior in five weekly 30 minute mating tests 
to determine their suitability for inclusion in the experiment.  Thereafter, twelve proven 
ejaculators were matched based on ejaculatory performance and assigned to two groups:  
E2-in-AMG (N = 6) or Vehicle-in-AMG (N = 6). 
 
Sexual behavior tests.  During sexual screening and postoperative mating tests, each 
male was paired with a receptive female for 30 minutes in a 22 x 44 x 50 cm testing arena 
under dim red light.  Tests began about 4 hours after lights off.  A laptop computer was 
used to tally mount frequency (MF), intromission frequency (IF) and ejaculation 
frequency (EF).  We also measured mount latency (ML - time from the start of the test 
until the first mount or intromission or 1800 seconds if no mounts occurred), ejaculation 
latency (EL - time from the first mount or intromission until the first ejaculation or 1800 
seconds if no ejaculations occurred) and the post-ejaculatory interval (PEI – time between 
an ejaculation and the next mount or intromission or 1800 seconds if no ejaculations 
occurred).   
 
Estradiol and Fadrozole administration to males.  Swanson’s atlas [146] was used to 
provide coordinates of the MEA: horizontal skull coordinates were –2.8 mm ap, 3.9 mm 
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ml, and –9.3 mm dv.  At the time of surgery, each male was anesthetized with sodium 
pentobarbital, 62.4 mg/kg i.p., and given atropine sulfate, 1.35 mg/kg i.m.  Bilateral 25 
gauge stainless steel implants were stereotaxically placed into the MEA and secured with 
jewelers screws to act as anchors for cranioplastic cement.  Antibiotic powder was 
applied and clips were used to close the incision.  E2-in-AMG males received air dried, 
ethylene oxide sterilized MEA implants whose tips had been coated with Silastic Medical 
Adhesive (Dow Corning) mixed with E2 (50.1 mg β-estradiol [Sigma] and 457 mg 
adhesive).  Vehicle-in-AMG males received implants whose tips had been coated with 
Silastic Medical Adhesive only (no E2).  In addition, all males were given Fadrozole s.c. 
via ALZET osmotic minipumps (model 2004, 200 μl capacity).  Pumps, loaded with 
27.18 mg Fadrozole/ml saline, dispensed the solution at the rate of 6 μl/day for 28 days; 
therefore, rats received a Fadrozole dose of 0.29 mg/kg/day.  Minipumps were filled, 
weighed, and immersed in physiological saline at 37o C for 48 hours prior to surgery, this 
ensured full pumping activity at the time of implantation.  Animals were given 5 to 7 
days recovery time before weekly behavioral testing was resumed.  Twenty-six days after 
implantation, each minipump was replaced under sodium pentobarbitol anesthesia with a 
second pump identical to the first, so that behavioral testing could be extended.  The 
testing schedule ensured a minimum of 5 days of recovery after minipump replacement 
before the next behavioral test.  Fluid levels in the pumps were checked at the end of the 
study to determine that there had been no pump failures; none occurred. 
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Immunocytochemical assays.  When the testing period was concluded, males were killed 
with an overdose of sodium pentobarbitol (150 mg/kg i.p.) and perfused transcardially for 
5 minutes with isotonic saline followed by a minimum of 300 ml 2% paraformaldehyde 
and 0.1% picric acid in 0.1 M phosphate buffer (PB) solution (pH 7.4).  Skulls were then 
partially opened and immersed over night in perfusion fixative.  Brains were removed 
from skulls the next day and stored in 30% sucrose in 0.1M PB for approximately 48 
hours. 
Coronal frozen brain sections (40 μm) were collected into 0.1 M PB.  Free 
floating sections through the diencephalon were obtained from each brain and matched 
sets of sections from both groups of males were processed concurrently using the same 
aliquots of diluted antisera and immunoreagents to minimize interassay variations.  
Sections were incubated for 24 hours in a blocking solution containing 3% normal goat 
serum and 0.2% Triton X-100 in 0.1M PB.  Sections were then incubated for 48 hours in 
1 μg/ml H222 (Abbott Laboratories), a rat monoclonal anti-ER antibody raised against 
the steroid-binding domain of a human ER protein fragment [55].  H222 anti-ER labeling 
is reported to be inhibited in brain by the presence of E2; conversely, labeling is present 
in the absence of E2 [6, 29, 30, 55].  The tissue was given three 5 minute washes in 0.1M 
PB and then incubated for 2 hours in a goat anti-rat gold-conjugated secondary antibody 
(BBI international, 1/250 dilution), followed by three 5 minute washes in deionized 
water, and a 20 minute incubation in silver enhancement reagents (BBI International) 
following the manufacturer’s directions.  After a final PB wash, sections were mounted 
on clean gel-albumin coated slides, cleared of salts and coverslipped using DPX.   
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There are problems with the use of the H222 anti-ER antibody in rat tissues  [6] 
due to the fact the H222 antibody was raised in rat [55].  The gold-conjugated secondary 
antibody used in this study was selected because it was the least cross-reactive in rat 
brain of several secondary antibodies we screened.   
 
Quantification and statistics.  H222-ir immunolabeling was mapped and quantified using 
Bioquant software (R & M Biometrics).  The numbers of H222 ER-ir neurons were 
counted in microscopic fields measuring 180 X 130 μm in sections from the MEA, MPO 
and ventromedial hypothalamus (VMH).  Histological data were analyzed by Mann 
Whitney U tests [133].   
Because a male that intromits necessarily mounts, but a male that mounts does not 
necessarily intromit, to find all sexually active animals we summed MF and IF for each 
rat and performed statistics on combined mounts and intromissions, as well as on EF (Fig 
19).  Behavioral data from all pretreatment and postoperative tests were assessed with 
repeated measures (group X trial) analysis of variance and Tukey HSD post hoc tests 
[69].  Two-tailed probability levels are reported in all cases. 
 
RESULTS 
Male Sexual Behavior 
Table 5 gives mean ± SEM MF, IF, ML, EL and PEI, and counts of the numbers 
of rats that were sexually active by mounts, intromissions or ejaculations.   
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Mounts and intromissions.  Both groups showed high levels of mounting and 
intromission during baseline before implantation, and there were no significant 
differences between them.  After implantation, mounts and intromissions declined 
significantly in males with vehicle in the amygdala compared to those with E2 in the 
amygdala F(8, 80) = 5.23, group by trial interaction, (p<0.001) (Fig. 19 top). During the 
first post-implantation treatment test, each group showed a significant decrease in these 
behaviors compared to baseline (p<0.01).  Thereafter, mounting and intromission 
recovered in males with E2 implants, and in several post-implantation treatment trials 
were not significantly different from baseline levels.  In contrast, mounting and 
intromission by males with vehicle in the amygdala remained significantly lower than 
baseline levels in all post-implantation treatment trials (p<0.01), and in several post-
implantation treatment trials were significantly lower than those of males with E2 in the 
amygdala (p<0.01) (Fig. 19 top).   
 
Ejaculations.  Both groups exhibited high and statistically indistinguishable levels of 
ejaculation in pretreatment baseline tests (Fig. 19 bottom).  During the post-implantation 
treatment period, EF declined significantly in both groups F(8,80)= 3.40, trial main 
effect,  (p<0.002), and did not recover.  In most post-implantation trials there were no 
consistent differences between E2-implanted and vehicle-implanted males.   
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Histology 
Implant placements.  Nissl sections showed that implant tips were widely distributed 
throughout the amygdala (AMG).  Locations of implants are depicted on standard atlas 
plates in Fig. 20. 
 
H222 ER-ir labeling.  Because E2 interferes with H222 ER-ir labeling in the brain [6, 29, 
30, 55], it was used to verify (i) that s.c. Fadrozole treatment inhibited formation of E2 
from T in the brain, and (ii) that E2 was confined to the AMG of experimental males.  
There was abundant H222 ER-ir labeling in the MPO (Fig. 21 A and B) and VMH (not 
shown) of both groups, as well as throughout the AMG of vehicle-implanted males (Fig. 
21 D), suggesting that Fadrozole s.c. blocked the local conversion of T to E2 in the brain.  
In the MEA (ap = -2.85, ml = 3.50, dv = 8.50, Swanson atlas [146]), H222 ER-ir labeling 
was substantially reduced or eliminated in E2-implanted males (Fig. 21 C); there were 
significantly fewer labeled neurons in these males than in vehicle-implanted males, 12.50 
± 7.16 versus 162.67 ± 58.73, respectively (U =3, n1 = 6, n2 = 6, p<0.02).  In contrast, 
there were no significant differences between the E2-in-AMG and the Vehicle-in-AMG 
males in the numbers of H222 ER-ir neurons in either the MPO, (267.67 ± 27.71 versus 
209.00 ± 49.84, respectively) or the VMH (27.50 ± 3.69 versus 35.17 ± 3.23, 
respectively).  The scarcity of labeling in the MEA and elsewhere in the AMG of E2-in-
AMG males was presumably due to the presence of E2 from the implants, and the 
occurrence of labeling in the MPO and VMH of these males suggests that the exogenous 
E2 had not diffused from the AMG to the MPO or VMH. 
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DISCUSSION 
Gonadally intact, sexually experienced male rats receiving Fadrozole s.c. together 
with E2 implants bilaterally to the AMG mounted and intromitted in most of the post-
implantation tests, and their behavior was not significantly different from pretreatment 
baseline levels.  Conversely, males that were treated with Fadrozole s.c. and received 
vehicle implants bilaterally to the AMG virtually ceased mating (Fig. 19).  Ejaculatory 
performance was not maintained by either treatment.   
In male mammals, T is enzymatically converted both centrally and peripherally 
by 5-alpha reductase to DHT and by aromatase to E2 [163].  Male copulatory behavior is 
restored or maintained in castrates by exogenous T [174] or by combined treatment with 
DHT and E2 [9, 84, 140, 158]), but not with E2 alone or with DHT alone [84, 92, 151, 
163].  Moreover, brain areas shown to be important for the display of male sexual 
behavior as evidenced by the expression of Fos-ir (a marker for neuronal activity [131]), 
including the MEA, have also been shown to contain populations of neurons that are 
sensitive to androgens as well as other neurons that are sensitive to estrogens [41, 50, 52, 
54] or both [51].   
Previous work has shown the importance of E2-sensitive neurons of the MPO, an 
area believed to be necessary for the display of male sexual behavior.  Bilateral irrigation 
of the MPO with Fadrozole significantly decreased mounts, intromissions and 
ejaculations in gonadally intact male rats, apparently because the MPO had been deprived 
of E2 derived from T [32].  Conversely, in a second study in which Fadrozole was 
administered s.c. to gonadally intact males and E2 was implanted bilaterally into the 
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MPO, levels of mounting and intromission and, to a lesser extent ejaculation, were 
maintained, suggesting that E2 sensitive neurons in the MPO contribute to all components 
of mating [33].  
Bilateral lesions of the MEA cause severe deficits in male rat mating behavior 
[71], suggesting that the MEA is also an area of critical importance in the display of male 
copulatory behavior.  In the present study, the same protocol used to study the role of the 
MPO, namely, systemic Fadrozole combined with intracerebral E2 implantation, was 
used here to study the AMG.  Because a pilot study [31] showed that mating was 
significantly inhibited in gonadally intact males receiving bilateral Fadrozole in the 
MEA, we hypothesized that local administration of E2 to the MEA of gonadally intact 
males with normal circulating testosterone levels would maintain mounting, intromission 
and ejaculation.  Testicular T was present in the rats but its aromatization to E2 was 
blocked in the MPO, VMH, MEA and presumably elsewhere in the brain by the 
administration of systemic Fadrozole, which significantly suppressed mating.  The effect 
of Fadrozole was partially reversed by implanting the brain with exogenous E2 aimed at 
the MEA, which maintained mounts and intromissions at pretreatment levels, but 
ejaculation was not maintained.  Follow-up brain histology suggested, however, that E2 
was probably present throughout the AMG.   
There was substantial variation in the locations of implants in the AMG.  H222 
ER-ir labeling in brain is inhibited by E2 [6, 29] and E2-in-AMG males had significantly 
less H222 ER-ir labeling of the MEA than Vehicle-in-AMG males.  Moreover, little 
H222 ER-ir labeling was observed elsewhere in the AMG of E2-in-AMG males, but was 
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abundant throughout the AMG of controls.  Thus, it is likely that much of the AMG was 
exposed to E2 in the E2-in-AMG group whereas little, if any, E2 was present in the AMG 
of Vehicle-in-AMG controls.  Estradiol apparently did not diffuse to brain sites remote to 
the AMG, such as the MPO and VMH.  We infer this because H222 ER-ir was abundant 
in the MPO and VMH of both groups.  There were no significant differences between 
groups in the numbers of H222 ER-ir MPO or VMH neurons, suggesting that Fadrozole 
inhibited the aromatization of T to E2 throughout the brain.  Accordingly, we cannot draw 
conclusions about where E2 acts in the AMG to facilitate mounting and intromission, 
although the histological data are consistent with the interpretation that E2 sensitive AMG 
neurons are important for sexual arousal but not for ejaculatory performance.   
Between test weeks 4 and 5, minipumps were changed to extend s.c. Fadrozole 
treatment.  Behavioral performance on test week 5 may have been influenced by 
minipumps that had not fully stabilized.  The data from week 5 are atypical yet 
interesting because they tend to rule out the possibility that incidental brain damage 
caused by the implantation procedures compromised sexual behavior.  This is because 
most of the Vehicle-in-AMG controls mated to ejaculation on test week 5, which 
contrasts with an otherwise statistically significant, progressive decline in mating (Fig. 19 
and Table 5).  Because incidental brain damage was similar in the E2-in-AMG and 
Vehicle-in-AMG groups, it cannot account for behavioral differences between 
experimentals and controls.  Consequently, these findings, in males with functional testes 
not compromised due to lack of circulating androgens, suggest that estrogen, acting in the 
amygdala, is necessary for sexual arousal (as reflected by mounting and intromission), 
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but not for ejaculation.  These findings also suggest that estrogen is important for 
ejaculatory performance, perhaps by acting in spinal and/or brain areas outside the 
amygdala. 
These findings extend previous reports showing that intracranial E2 administration 
to the AMG partially restored mounting in castrated male rats [126] and hamsters [167], 
but not to pre-castration levels.  Testosterone may also be needed for normal levels of 
sexual behavior, since other studies showed that T implants to the male hamster MEA 
restored mounts and intromissions or mounts alone [168, 169,].  The findings from the 
present study suggest that such effects may depend on the aromatization of T to E2 in the 
AMG, because Vehicle-in-AMG males (exposed to testicular T but not to E2) virtually 
ceased mating, whereas E2-in-AMG males that had circulating T together with E2 in the 
AMG mounted and intromitted at pretreatment levels.   
This study raises questions concerning the cell types and brain areas that mediate 
specific components of mating behavior.  One might interpret these results to imply that 
the AMG is a site that controls mounting and intromission, and that the expression of 
these behaviors is E2 dependent.  If this is the case, then ER-containing cells in the AMG 
are not unique because other brain areas also contain E2-responsive neurons that 
contribute to mounting and intromission, e.g. the MPO [32, 33].  Redundancy might 
explain why disabling different individual brain areas results in the same behavioral 
display [40], although often the quality of the behavior varies.  Thus, redundancy does 
not necessarily imply equal facilitation of sexual behavior among different brain nuclei 
[171].  This study, together with previous findings [31-33], suggests that E2 acts in the 
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AMG and MPO to mediate mating, which that suggests that a network of E2-sensitive 
neurons are important for male sexual behavior.  Questions remain as to whether the 
AMG and MPO function as separate entities or as a unit [40, 74, 171] to mediate male 
sexual behavior.  Findings from this study suggest that E2-sensitive AMG neurons 
mediate sexual arousal or motivation but not ejaculatory performance. 
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FIGURE 19 
Effects on the numbers (mean ± SEM) of mounts and intromissions (top) and ejaculations 
(bottom) of implanting E2 (closed circles and solid lines) or vehicle (open circles and 
interrupted lines) bilaterally into the AMG of intact male rats receiving Fadrozole s.c.  In 
E2-implanted males, post-implantation levels of mounts and intromissions remained high, 
but ejaculations decreased significantly (p<0.01) in most post-implantation tests.  In 
vehicle-implanted males, there was a significant (p<0.01) post-implantation decline in 
mounts and intromissions as well as in ejaculations. 
 
 178
 
FIGURE 19 
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FIGURE 20 
Location of implant tips in E2-implanted males (closed circles N = 6) and in vehicle-
implanted males (open circles, N = 6).   
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FIGURE 20 
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FIGURE 21 
Photomicrographs of representative sections from the medial preoptic area (MPO, panels 
A and B) and the medial amygdala (MEA, panels C and D) from Fadrozole-treated male 
rats implanted bilaterally in the AMG with either E2 (A and C) or vehicle (B and D).  The 
photomicrographs in A and C, and B and D, are from the right side of one animal in the 
E2-in-AMG group and the right side of one animal in the Vehicle-in-AMG group, 
respectively.  Neuronal labeling by the H222 anti-ER antibody, which is reduced by the 
presence of estrogen, was abundant in the MPO of both E2-implanted and vehicle-
implanted males and in the MEA of the vehicle-implanted male (A, B, D), but was 
substantially suppressed in the MEA of the E2-implanted male (C).  This suggests that E2 
was present in the MEA of E2-implanted, but not of vehicle-implanted, males, and that E2 
in the former had not diffused to the MPO.  Scale bar = 300 μm. 
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FIGURE 21 
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TABLE 5 
Mean ± SEM* Behavioral Indices and Numbers of Rats Exhibiting Specific Behaviors by Group 
 
ESTRADIOL 
in 
AMG 
 
 
Test 
Week 
  __ 
 X ± 
SEM 
MF* 
__ 
 X ± 
SEM 
  IF* 
   __ 
 X ± 
SEM 
ML* 
    __  
X ± 
SEM 
 EL* 
    __ 
X ± 
SEM 
  PEI* 
#Rats: 
M/I/E 
(MI)† 
-4 
33.67 
± 5.80 
13.00 
± 4.27 
152.83 
± 78.10 
1293.17 
± 231.72 
555.83 ± 
248.87 6/6/5 (6) 
-3 
32.67 
± 6.71 
32.83 
± 4.69 
36.17 ± 
21.32 
885.83 ± 
228.62 
560.33 ± 
248.18 6/6/5 (6) 
-2 
28.00 
± 3.82 
20.17 
± 5.33 
39.67 ± 
17.83 
963.33 ± 
277.28 
792.17 ± 
319.09 6/6/4 (6) 
-1 
42.50 
± 9.86 
15.00 
± 4.28 
106.67 
± 52.08 
1105.50 
± 313.72 
1044.83 
± 337.74 6/5/3 (6) 
0 
29.00 
± 7.45 
16.83 
± 3.81 
133.83 
± 
105.01 
1124.33 
± 200.62 
570.50 ± 
252.77 6/5/5 (6) 
1 
6.50 ± 
3.08 
5.17 ± 
3.29 
839.50 
± 
339.36 
1622.00 
± 178.00 
1560.83 
± 239.17 4/2/1 (4) 
2 
23.17 
± 6.48 
20.50 
± 4.80 
149.83 
± 
122.47 
1615.83 
± 184.17 
1555.17 
± 244.83 6/5/1 (6) 
3 
37.00 
± 8.68 
16.67 
± 6.18 
254.50 
± 
226.16 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
6/5/0 
(6) 
4 
26.00 
± 6.27 
18.00 
± 4.35 
124.67 
± 94.88 
1626.50 
± 122.11 
1319.83 
± 303.85 6/6/2 (6) 
5 
18.50 
± 7.07 
8.17 ± 
3.23 
519.17 
± 
290.58 
1738.67 
±  
61.33 
1573.83 
± 226.17 5/4/1 (5) 
6 
25.50 
± 8.29 
7.33 ± 
4.13 
238.83 
± 
155.15 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
6/4/0 
(6) 
7 
15.17 
± 6.36 
11.83 
± 5.36 
726.33 
± 
348.82 
1413.83 
± 205.51 
1015.67 
± 352.60 4/4/3 (4) 
8 
28.83 
± 
10.75 
15.67 
± 3.80 
275.67 
± 
103.80 
1616.33 
± 127.76 
1354.83 
± 282.79 6/5/2 (6) 
 
*Mean (X) ± standard error of mean (SEM):  MF=mount frequency, IF=intromission frequency, ML=mount 
latency, EL=ejaculation latency, PEI=post-ejaculatory interval 
†Number (#) that:  M=mounted, I=intromitted, E=ejaculated, MI=mounted or intromitted (were sexually active) 
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TABLE 5 (continued) 
Mean ± SEM* Behavioral Indices and Numbers of Rats Exhibiting Specific Behaviors by Group 
 
VEHICLE 
in 
AMG 
 
 
Test 
Week 
  __ 
 X ± 
SEM 
MF* 
__ 
 X ± 
SEM 
  IF* 
   __ 
 X ± 
SEM 
ML* 
    __  
X ± 
SEM 
 EL* 
    __ 
X ± 
SEM 
  PEI* 
#Rats: 
M/I/E 
(MI)† 
-4 
31.00 
± 4.18 
19.67 
± 1.99 
71.00  
±  
28.73 
1400.50 
± 189.09 
1065.17 
± 328.84 6/6/3 (6) 
-3 
42.33 
± 4.22 
29.50 
± 4.23 
27.00  
±  
10.90 
911.67 ± 
199.41 
531.83 ± 
255.65 6/6/5 (6) 
-2 
36.00 
± 3.63 
23.17 
± 2.56 
47.33  
±  
9.72 
649.33 ± 
113.53 
306.83 ± 
21.88 6/6/6 (6) 
-1 
38.67 
± 4.96 
24.00 
± 4.26 
64.83  
±  
34.48 
1133.33 
± 249.32 
591.83 ± 
242.67 6/6/5 (6) 
0 
39.17 
± 6.04 
26.17 
± 3.70 
77.00  
±  
45.46 
1271.67 
± 334.26 
1244.50 
± 352.61 6/6/2 (6) 
1 
6.33 ± 
5.19 
1.17 ± 
0.98 
1001.83 
± 
358.85 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
3/2/0 
(3) 
2 
18.67 
± 7.88 
11.67 
± 4.14 
691.67 
± 
352.07 
1602.17 
± 197.83 
1572.67 
± 227.33 4/4/1 (4) 
3 
4.50 ± 
4.50 
1.00 ± 
1.00 
1591.67 
± 
208.33 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
1/1/0 
(1) 
4 
4.67 ± 
4.67 
1.83 ± 
1.83 
1565.33 
± 
234.67 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
1/1/0 
(1) 
5 
10.33 
± 3.53 
14.17 
± 4.69 
652.00 
± 
363.65 
1409.83 
± 196.65 
841.83 ± 
307.71 4/4/4 (4) 
6 
0.00 ± 
0.00 
0.00 ± 
0.00 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
0/0/0 
(0) 
7 
2.67 ± 
2.29 
0.33 ± 
0.33 
1309.50 
± 
311.35 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
2/1/0 
(2) 
8 
0.00 ± 
0.00 
0.00 ± 
0.00 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
1800.00 
±  
0.00 
0/0/0 
(0) 
 
*Mean (X) ± standard error of mean (SEM):  MF=mount frequency, IF=intromission frequency, ML=mount 
latency, EL=ejaculation latency, PEI=post-ejaculatory interval 
†Number (#) that:  M=mounted, I=intromitted, E=ejaculated, MI=mounted or intromitted (were sexually active) 
